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Abstract 
 
 
 
Recently, prevention of cancer through dietary intervention has received an increasing interest. 
In particular, dietary polyphenols mainly found in fruits and vegetables have become very attractive as 
chemopreventive and therapeutic agents. 
The main aim of this work was to investigate the potential activity of Portuguese Opuntia spp. 
on colon cancer therapy, as this fruits have been reported to be rich sources of bioactive compounds. 
Opuntia spp.  fruits were collected in different sites  of Portugal,  namely Tramagal, Beja, 
Marvão Sines and Quarteira and processed in order to obtain fruit juices, polyphenol-rich concentrates 
and  residues  extracts  from  fruit  juices  production.  All  Opuntia  products  were  investigated  for 
antiproliferative activity of human colon cancer cells (HT29). Opuntia juices from Tramagal, Sines 
and Quarteira were the most  effective on cancer cell growth inhibition due to the highest content in 
total polyphenol content and betalains. 
The most promising extracts were derived from Quarteira, Sines and Beja fruit juices residues 
using  conventional  solvent  extraction,  adsorption  technology  and  pressurized  liquid  extraction, 
respectively. These extracts showed high antiproliferative effect inducing cell cycle arrest in different 
checkpoints. Additionally, the same extracts showed to induce ROS production in cancer cells, playing 
an important role in activation of pro-apoptic cell death mechanisms. 
The capacity of natural extracts in reverting chemoresistance of tumor cells was evaluated on a 
drug-resistant HT29 cell culture. The product derived from Beja residue using pressurized liquid 
extraction with 60%CO2  and 40%EtOH showed to increase cells sensitivity to the drug. 
Opuntia spp. fruits reveled to be promising natural sources for the production of functional 
 
products as well as for the development of novel chemotherapeutic agents. 
 
 
 
Keywords: Colon cancer; polyphenols; Opuntia spp.; antiproliferative effect; chemoresistance. 
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Resumo 
 
 
 
Recentemente tem surgido um grande interesse na prevenção do cancro através da dieta. Em 
particular, os polifenóis presentes nas frutas e nos vegetais são reconhecidos como sendo compostos 
muito atractivos na área da quimioprevenção e terapia do cancro. 
O principal objectivo deste trabalho consistiu na avaliação da potencial actividade de frutos de 
Opuntia spp. Portugueses para terapia do cancro do cólon, uma vez que este frutos são reconhecidos 
como sendo fontes ricas em compostos bioactivos. 
Os frutos de Opuntia spp. foram recolhidos em diferentes regiões de Portugal, nomeadamente 
Tramagal, Beja, Marvão, Sines e Quarteira, e foram processados para obter sumos de fruta, extractos 
concentrados em polifenóis e extractos de resíduo obtidos a partir do processamento dos sumos de 
fruta. Todos os produtos foram analisados em termos de actividade antiproliferativa numa linha celular 
humana de cancro do cólon (HT29). Os sumos de fruta provenientes de Tramagal, Sines e Quarteira 
foram os  mais  efectivos  na  inibição do crescimento  das  células  cancerígenas  devido ao  elevado 
conteúdo em polifenóis e à presença de betalainas. 
Os extractos mais promissores foram obtidos a partir dos resíduos dos sumos de Quarteira, 
Sines e Beja, usando tecnologias limpas como a extracção convencional, tecnologia de adsorção e a 
extracção com solventes pressurizados. Os extractos obtidos demonstraram um efeito antiproliferativo 
elevado e induziram a  paragem do ciclo celular em fases distintas. Para além disso induziram a 
produção de espécies reactivas de  oxigénio (ROS) a nível celular, desempenhando assim um papel 
importante na activação de mecanismos pro-apoptóticos de morte celular. 
Neste  trabalho  foi  também  avaliada  a  capacidade  dos  extractos  naturais  em  reverter  a 
quimioresistência em células resistentes à doxorubicina, uma droga anticancerígena. O extracto obtido 
por extracção com solventes pressurizados, nomeadamente 60%CO2  e 40% EtOH, a partir do resíduo 
de Beja, demonstrou aumentar a sensibilidade à droga nas células resistentes. 
Os resultados  obtidos  nesta tese demonstraram que os frutos  de Opuntia spp.  são fontes 
promissoras para a produção de produtos funcionais  e para o desenvolvimento de novos agentes 
naturais para aplicação em quimioterapia. 
 
 
Palavras-chave: cancro do cólon; polifenóis; Opuntia spp.; actividade antiproliferativa; 
 
quimioresistência. 
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1.1 Introduction 
 
1.1 Cancer worldwide 
 
Cancer is a leading cause of mortality in human and a growing health problem all around the 
world.   One defining feature of cancer is the rapid creation of abnormal cells that grow beyond their 
usual boundaries and spread to other organs, creating metastasis (Haque, et al., 2010).  According to 
Cancerbase  GLOBOCAN,  in  2008,  more  than  12  million  new  cases  of  cancer  were  registered 
(excluding non-melanoma skin cancer) while 7.5 million people died from cancer worldwide. In 2020 
it is estimated that mortality from cancer will increase to more than 10 million (Ferlay J, et al., 2010). 
Since there are no particular treatment of cancer, effective preventive measures and cancer 
awareness among the general population is essential. Many clinical and laboratory studies support that 
our lifestyle and dietary factors are playing a complex multifaceted role in etiology of cancer (Haque, 
et al., 2010).  Several organizations such as: World Health Organization (WHO), American Cancer 
Society (ACS),  American Institute of Cancer Research (AICR) and National Cancer Institute (NCI) 
have established dietary guidelines to help people reduce the cancer risk (Surh, 2003). 
 
 
1.1.1 Colorectal Cancer 
 
1.1.1.1 Epidemiology, etiology and causes 
 
Colorectal cancer (cancer of the colon and/or rectum) is the third most common cancer in men 
(663 000  cases, 10.0% of the total) and the second in women (571 000 cases, 9.4% of the total) 
worldwide (Ferlay  J,  et  al.,  2010).  In 2008,  about  608  000  deaths  from colorectal  cancer  were 
estimated, accounting for 8% of all cancer deaths, making it the fourth most common cause of death 
from cancer in world. Almost 60% of the cases occur in developed regions, but colon cancer incidence 
is now increasing in middle and low income countries (see table 1.1) (Ferlay J, et al., 2010). 
Colon cancer is defined as any malignant neoplasm arising from the inner lining of the colonic 
epithelium (Rajamanickam and Agarwal, 2008). According to the 2007 Report of the World Cancer 
Research Fund/American Institute of Cancer Research (WCRF/AICR), approximately 95 per cent of 
colorectal cancers are adenocarcinomas. However other types of cancer can occur, including mucinous 
carcinomas and adenosquamous carcinomas. The occurrence of colon cancer is strongly related with 
age, 90% of the cases arising in people who are 50 years or older. Survival rates for colon cancer can 
vary based on a variety of  factors, particularly the stage. If the cancer is detected at an early and 
localized stage, the five-year survival rate (the percentage of people who survive at least five years 
after the cancer is detected, excluding those  who die from other diseases) is 90%. However, when 
metastasis occur, the 5-year survival rate decrease to 10% (American Cancer Society, 2008). 
Etiologically,  colorectal  cancer  may  be  hereditary  or  sporadic  (Young,  et  al.,  2005). 
Epidemiological studies have suggested that colon cancer is a manifestation of a number of inherited 
cancer predisposition syndromes, including familial adenomatous polyposis, hereditary non-polyposis 
 
 
 
1 
colorectal cancer, personal or family history of colorectal cancer and/or polyps and inflammatory 
bowel  disease (Rowley, 2005). On the other hand, sporadic colorectal cancers are due to somatic 
genetic  mutations  that  occur  as  part  of  the  normal  cellular  lifespan  or  because  of  exposure  to 
environmental factors (Young, et al., 2005). Known causes of colon cancer include tobacco smoking, 
obesity and lack of  exercise, infectious agents, medication, radiation, industrial chemicals, alcohol 
consumption and diet rich in high fat, red and processed meats. Moreover, inadequate intake of dietary 
fiber, fruits and vegetables are also associated with the increase of colon cancer risk (Haque, et al., 
2010, Kushi, et al., 2006, Rajamanickam and Agarwal, 2008). 
 
 
 
Table 1.1. Colorectal Cancer Incidence and Mortality Worldwide in 2008. Numbers are expressed in  thousands 
 
(adapted from Ferlay J, et al., 2010). 
 
 Men Women Both sexes 
Cases Deaths Cases Deaths Cases Deaths 
World 663 320 571 288 1234 608 
More developed regions 389 165 338 154 727 319 
Less developed regions 274 154 232 134 506 288 
WHO Africa region (AFRO) 14 11 12 9 26 20 
WHO America region (PAHO) 122 46 118 49 240 95 
WHO East Mediterranean region (EMRO) 13 9 10 7 23 16 
WHO Europe Region (EURO) 238 115 212 107 450 222 
WHO South-East Asia region (SEARO) 50 34 47 32 97 66 
WHO Western Pacific region (WPRO) 224 101 170 81 394 182 
IARC membership (21 countries) 368 151 316 141 684 292 
United States of America 79 24 74 26 153 50 
China 125 61 95 48 220 109 
India 20 14 16 11 36 25 
European Union (EU-27) 182 80 151 68 333 148 
 
 
1.1.1.2 Chemoteraphy and chemoprevention: a perfect combination 
 
Conventional cancer therapies, including surgery, chemotherapy, and radiotherapy have a 
significant role in the overall treatment of tumors (Sarkar and Li, 2006). In particular chemotherapy 
has high  treatment success rates in various types of cancer. However, the main drawback of this 
therapy consists  on  the multidrug-resistance (MDR)  effect  of cancer  cell (De Boo,  et  al.,  2009, 
Riganti, et al., 2005, Sarkar and Li, 2006, Schonn, et al., 2011). A variety of mechanisms by which 
cancer cells acquire the MDR  phenotype have been described, including the reduced uptake or the 
increased efflux of the drug, the genetic  modification of the drug's specific targets, the increased 
ability   to  repair   DNA damage,   the   reduced capacity   to   enter   apoptosis, the   different 
compartmentalization and the increased rate of drug detoxification (Ferreira, et al., 2002, Gottesman, 
2002). Thus, the cell resistance to anticancer drugs and the failure of chemotherapy to treat some 
 
cancers lead to development of new therapies. The strategies of cancer treatment using combined 
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therapies or combined agents with distinct molecular mechanisms are considered very promising for 
higher efficacy, resulting in better survival (Hwang, et al., 2005, Sarkar and Li, 2006). For this reason, 
chemoprevention, which involves the use of specific natural products or synthetic chemical agents to 
reverse, suppress or prevent premalignancy before the development of invasive cancer, has appeared 
as a novel approach for controlling this malignant disease (Haque, et al., 2010, Rajamanickam and 
Agarwal, 2008, Ramos, 2008). 
In  terms  of  molecular  perspective,  carcinogenesis  is  a  multistage  process  consisting  on 
initiation,  promotion  and  progression  phases  which  involves  sequential  generations  of  cells  that 
exhibit continuous disturbance of cellular and molecular signal cascades (Vincent and Gatenby, 2008) 
(figure 1.1). The initiation stage comprises the exposure or uptake of cells with a carcinogenic agent 
causing  a  genetic  alteration.  In  the  promotion  stage  abnormal  cells  persists,  replicates  and  may 
originate a focus of preneoplastic cells. Finally in the last stage – progression - there is an uncontrolled 
growth of the cells (tumor) that involves the gradual conversion of premalignant cells to neoplastic 
ones  with an increase of invasiveness  and  metastasis  potential,  and new blood  vessel formation 
(angiogenesis) (Ramos, 2008). During this multistage sequence of events there are many phases for 
intervention to inhibit, reverse and/or delay the progress of cancer (Johnson, 2007). 
 
 
 
 
Figure 1.1. Sequence of multistage carcinogenesis process (Ramos, 2008). 
 
 
 
In recent years, dietary compounds have been recognized as cancer chemopreventive agents 
owing to their various health benefits and noticeable lack of toxicity and side effects (Manson, et al., 
2005, Sarkar and Li, 2006). Common cancer therapies combined with these dietary compounds may 
 
exert  enhanced antitumor activity through synergic action or compensation of inverse properties. 
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Moreover,   the  combination  treatment   may  decrease  the  systemic  toxicity  caused  by   many 
chemotherapeutic drugs because lower doses could be used (Sarkar and Li, 2006). It is known that 
these  compounds  exert the anticarcinogenic activity through regulation of different cell signaling 
pathways (figure 1.2). Chemopreventive agents can affect all stages of carcinogenesis by inducing cell 
cycle  arrest  and  apoptosis,  decreasing  cell  proliferation  and  angiogenesis,  inhibiting  tumor  cell 
invasion and metastasis,  and  modulating various signal transduction as well as COX-2/PGE2 and 
Wnt/β-catenin pathways, involved in colon cancer development (Dragnev, et al., 2007) 
 
 
Figure 1.2. Mechanisms of action of natural products in colon cancer chemoprevention  (Rajamanickam and 
Agarwal, 2008). 
 
 
1.1.1.3 Food and nutrition on cancer chemoprevention 
 
According to WCRF/AICR 2007 report, 30-40% of cancer could be preventable over time by 
appropriate food and nutrition, regular physical activity, and avoidance of obesity. On a global scale 
this  represents over 3 to 4 million cases of cancer that can be prevented in these ways, every year 
(WCRF/AICR, 2007). As table 1.2 shows, colorectal cancer are greatly or mostly affected by food and 
nutrition. It is proven that physical activity and foods containing dietary fiber protect against colorectal 
cancer while foods, like red and  processed meat, alcoholic drinks, body fatness and others factors 
increase risk of the disease. However, the findings that fruits and vegetables can protect against colon 
cancer are not yet conclusive, suggesting a limited-suggestive role (WCRF/AICR, 2011). Despite that, 
several epidemiological studies have reported an  inverse correlation between decreased cancer risk 
and  high  consumption  of  vegetables,  including  cabbage,  cauliflower,  broccoli,  brussels  sprout, 
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tomatoes, and fruits such as, apples, grapes, and berries (Gordaliza, 2007, Vainio and Weiderpass, 
 
2006). 
 
The assessing of the real impact of dietary constituents on human health is difficult because in 
many cases the exact composition of foods and the bioavailability of active molecules are not known. 
The most direct  evidence of beneficial effects by a particular food rich in certain compounds have 
come from animal models and in vitro experiments. In fact, cell culture studies constitute a valuable 
tool for identifying the molecular  targets  modulated by food compounds  in cancer cells and for 
elucidating the molecular pathways involved in the overall disease process (Ramos, 2008). 
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 Decrease risk Increase risk 
 
 
 
 
 
Convincing 
 
 
 
- Physical activity 1 
 
- Foods containing dietary  fiber 
- Red meat 
 
- Processed meat 
 
- Alchololic drinks (men) 2 
 
- Body fatness 
 
- Abdominal fatness 
 
- Adult attained height 3 
 
 
Probable 
- Garlic 
 
- Milk 
 
- Calcium 
- Alcoholic drinks (woman) 2 
 
 
 
 
 
Limited - 
suggestive 
- Non-starchy vegetables 
 
- Fruits 
 
- Foods containing folate 
 
- Foods containing selenium 
 
- Fish 
 
- Foods containing vitamin D 
 
- Selenium 
- Foods containig iron 
 
- Cheese 
 
- Foods containing animal fats 
 
- Foods containing sugars 
 
 
 
 
Limited - no 
conclusion 
- Cereals (grains) and their products; potatoes; poultry; shellfish and other 
seafood; other dairy products; total fat; fatty acid composition; cholesterol; 
sugar (sucrose); coffee; tea; caffeine; total carbohydrate; starch; vitamin A; 
retinol; vitamin C; vitamin E; multivitamins; non-dairy sources of calcium; 
methionine; beta-carotene; alpha-carotene; lycopene; meal frequency; energy 
intake 
 
Table 1.2. The factors that modify the risk of cancers of the colon and the rectum. Judgments are graded according 
to   the   strength   of   the   evidence   by   the   Panel   of   WCRF/AICR   Continuous   Update   Project   2011   (adapted 
from WCRF/AICR, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1  Physical activity of all types: occupational, household, transport, and recreational. The Panel judges that the 
evidence for colon cancer is convincing. No conclusion was drawn for rectal cancer. 
2 The judgments for men and women are different because there are fewer data for women. Increased risk is only 
apparent above a threshold of 30 g/day of ethanol for both sexes. 
3    Adult  attained  heights  are  unlikely  directly  to  modify  the  risk  of  cancer.  It  is  a  marker  for  genetic, 
environmental, hormonal, and also nutritional factors affecting growth during the period from preconception to 
completion of linear growth. 
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1.2 Polyphenols and health-promoting effects 
 
“Polyphenols” (or  phenolic compounds) is  a  generic term that  refers  to  more than 8000 
compounds   widely   dispersed   throughout   the   plant   kingdom   (Cartea,   et   al.,   2011).   These 
phytochemicals are secondary metabolites and have considerable physiological and morphological 
functions. Polyphenols may act as phytoalexins, antifeedants, attractants for pollinators, contributors 
to plant pigmentation, antioxidants and protective agents against UV light, among others (Naczk and 
Shahidi, 2006). These bioactive properties play an important role in plant growth and reproduction and 
providing  an  efficient   protection  against  pathogens  and  predators.  Additionally, polyphenols 
contribute to the color and sensory characteristics of many fruits and vegetables (Cartea, et al., 2011, 
Jaganath and Crozier, 2010, Zitka, et al., 2011). 
Polyphenolic compounds derived from phenylalanine and are characterized by having at least 
one aromatic ring with one or more hydroxyl groups attached. They are divided into several classes 
according to the number of phenol rings that they contain and the structural elements that bind these 
rings to one another  (D'Archivio, et al., 2007). The main groups of polyphenols are flavonoids (eg: 
quercetin), phenolic acids (eg: chlorogenic acid), stilbenes (eg: resveratrol) and lignans (enterodiol). 
Flavonoids and phenolic acids account for 60 and 30%, respectively, of dietary polyphenols (figure 
1.3) (Scalbert and Williamson, 2000). 
 
 
 
 
 
Figure  1.3.  Chemical  structures  of  the  main  classes  of  polyphenols  (adapted  from Scalbert  and 
Williamson, 2000). 
 
 
Polyphenols are widespread constituents of fruits, vegetables, cereals, olive, dry legumes, 
chocolate and beverages, such as tea, coffee and wine (D'Archivio, et al., 2007). They have a great 
interest in the industry because they have many applications as food preservatives and colorants or in 
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production of paints, papers and cosmetic (Ignat, et al., 2011). However, in last decade, polyphenols 
have  received  much  more  attention  for  their  health  benefits. The most  well-know  property  of 
polyphenols is their antioxidant capacity - the ability of a food constituent to enhance the endogenous 
antioxidant  defense  system (Lila, 2007). Reactive oxygen species (ROS), derived from oxidation 
processes, are an important part of the defense mechanisms against infection, but excessive generation 
of free oxygen radicals  may damage  the  tissue.  When there is  an imbalance between ROS  and 
antioxidant defense mechanisms, the ROS lead to the oxidative modification of cellular membranes or 
intracellular  biomolecules  and  result  in  the   peroxidation  of  membrane  lipids,  leading  to  the 
accumulation of lipid peroxides (Cartea, et al., 2011). Therefore, as antioxidants, polyphenols can trap 
ROS  in the human body, protecting cells against oxidation damage and consequently limit the risk of 
several pathologies associated to oxidative stress (Cartea, et al., 2011, D'Archivio, et al., 2007, Lila, 
2007, Ramos, 2008). In more detail, polyphenolic compounds can prevent the DNA-damage caused 
by free  radicals or carcinogenic agents through different mechanisms: (i) direct radical scavenging 
(Alía, et al., 2006,  Sonee, et al., 2004), (ii) chelating divalent cations involved in Fenton reaction 
(Nakagawa, et al., 2004) and  (iii) modulation of enzymes related to oxidative stress (glutathione 
peroxidase, glutathione reductase,  nitricoxide sinthase, lipooxygenase, xanthine oxidase, etc.) (Alía 
(a), et al., 2006, Alía(b), et al., 2006). Besides their antioxidant activity, several studies have revealed 
that polyphenols exhibit an extensive spectrum of others biological activities such as, stimulation of 
the  immune system,  antibacterial,  antiviral,  anti-hepatotoxic,  anti-ulcer,  anti-inflammatory  ,  anti- 
mutagenic, and anticancer effects (figure 1.4) (Zitka, et al., 2011). 
 
 
Figure 1.4. Polyphenols and their biological properties (adapted from Zitka, et al., 2011). 
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Dietary polyphenols can also act as pro-oxidants depending on the cell type, dose and/or time 
of treatment, having opposite effects on basic cell physiological processes: if as antioxidants they 
improve cell survival, as pro-oxidant they may induce apoptosis and block cell proliferation (Lambert, 
et al., 2005). Because of these several effects and properties, polyphenols  may confer protection 
against several pathologies, such as cardiovascular disease, cancer, osteoporosis, diabetes mellitus and 
neurodegenerative diseases (Parkinson`s and Alzheimer`s disease) (Scalbert, et al., 2005). 
Many studies in different cell lines and animal models suggest a protective role of dietary 
polyphenols against colorectal cancer (table 1.3) (Araújo, et al., 2011). According to Ramos (2008), 
there are  6  main common chemopreventive effects that polyphenols can exert on cancer cells: (1) 
antioxidant effect; (2) antiproliferation and antisurvival effect; (3) induction of cell cycle arrest, (4) 
induction o apoptosis, (5) anti-inflammatory effect, and (6) inhibition of angiogenesis and metastasis. 
It is important to note that phenolic compounds are less potent that pharmaceutical drugs but 
since they are ingested regularly in significant amounts as part of the diet, they may have a noticeable 
long-term physiological effect (Espín, et al., 2007). The average dietary intake of polyphenols varied 
between 0.1 and 1  g/d in occidental Europe and the United States population but only 10% are 
absorbed upper  gastrointestinal  track (Manach, et al., 2004). For that reason, when compared with 
other   organs   and   tissues,   the  intestinal  region   has   been  pointed  as  a   promising  site  for 
chemoprevention due to the  higher exposition doses of dietary polyphenols (Manach, et al., 2004, 
Scalbert and Williamson, 2000). As  example, after the ingestion of 250 to 500 mg of polyphenol 
supplements the lumen of the colon can be exposed to concentrations around 0.1 to 3 mmol/L (Dihal, 
et al., 2006, Scalbert and Williamson, 2000) whereas the plasma concentrations are around 1µmol/L 
(van der Woude, et al., 2003). 
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Table 1.3.  Mechanisms involved in the chemopreventive effect of polyphenols in colorectal cell lines (adapted 
from Araújo, et al., 2011). 
 
Polyphenol Cell type Cellular mechanism 
 
Quercetin HT29, Caco2, SW480, HCT-116, 
IEC-6, FHC, VACO-235, COLO 
201, LS-174T, T84, DLD-1, LT97, 
rat and mouse colonocytes 
Cell growth inhibition and cytotoxic activity; reduction 
or stimulation of cell proliferation; decrease of cell 
migration; induction of cell cycle arrest, differentiation, 
apoptosis, and autophagy 
 
 
Rutin HT29 and Caco2 Inhibition or no alteration of cell proliferation, 
differentiation, and apoptosis 
 
Myricetin HT29, Caco2, SW480, T84, 
VACO-235, COLO 205 
Cell growth inhibition; reduction of cell proliferation; 
induction of apoptosis; antimetastatic properties 
 
 
Chrysin HT-29, Caco-2, SW480 Cell growth inhibition; reduction of cell proliferation; 
induction of cell cycle arrest and apoptosis 
 
EGCG HT29, Caco2, SW480, SW837, 
SW426, HCT-116, FHC, T84, 
murine colon 26-L5, mouse colon 
26 
Inhibition of cell growth, proliferation, neoplastic 
transformation, invasion, and angiogenesis; induction 
of cell cycle arrest and apoptosis 
Epicatechin HT29 Weak or absent growth-inhibitory and apoptotic 
activity 
 
Catechin HT29 Weak or absent growth-inhibitory and apoptotic 
activity 
 
Resveratrol HT29, SW480, Caco2, SW620, 
HCT-116, CCL 220.1, WiDr 
Inhibition of cell growth; induction of apoptosis; arrest 
of proliferation, cell cycle, and neoplastic 
transformation 
 
Xanthohumol HT29, CCL 220.1, HCT-116– 
derived 40-16 
Inhibition of cell growth, proliferation, invasiveness, 
and angiogenesis; induction of apoptosis, terminal 
differentiation, and cell cycle arrest 
 
 
 
Combination of 
polyphenols 
HT29, Caco2, SW480 Inhibition of cell growth and proliferation; induction of 
apoptosis 
 
Combination of 
polyphenols with 
therapeutic drugs 
HT29, mouse colon 26 Inhibition of cell growth and proliferation; induction of 
apoptosis 
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1.3 Opuntia spp. 
 
The prickly  pear  cactus  (Opuntia  spp.)  or  cactus  pear  belongs  to  the  Cactaceae  family 
(Feugang, et al., 2006) and is a long-domesticated crop critically important in agricultural economies 
throughout the arid and semiarid parts of the world, where water can be a limitation for cultivation 
(Griffith,  2004). It is widely distributed in Europe, Southwestern United States, Northern Mexico, 
much of Latin America, South Africa and the Mediterranean countries (Utkarsha, et al., 2010). 
Two parts of the plant have been used for food: the „„nopal‟‟ or cladodes (stems) and the fruits 
or the  prickly pears (figure 1.5). In particular, cladodes are consumed in Mexican regions as a 
constituent of salads (Medina, et al., 2007) while Opuntia spp. fruits are known to be fresh and sweet 
fruits  that can be eaten fresh, dried or preserved in jams, syrups or processed into candy-like products 
(Galati, et al., 2003, Medina, et al., 2007). 
 
 
 
 
Figure 1.5. Images of Opuntia spp. cladodes and fruits. 
 
 
 
Opuntia fruits are fleshy and elongated berries, varying in shape, size and color (orange, 
yellow, red, purple, green, white) and have a consistent number of hard seeds (Piga, 2004). This fruit 
was ignored by the scientific community until the beginning of the 1980s when several lab reports and 
studies demonstrated their biological activity. Recently, investigations on the chemical components 
and  the  nutritional  value  of  Opuntia  spp.  have  attracted  attention  in  the  food,  nutritional  and 
pharmacological field (Feugang, et al., 2006, Hernández-Pérez, et al., 2005, Piga, 2004, Saenz, 2000, 
Stintzing, et al., 2001). Nowadays it is known that Opuntia spp. fruits are sources of several bioactive 
and  nutritionally  valuable  compounds  (Cayupán,  et  al.,  2011,  Utkarsha,  et  al.,  2010)  and  their 
concentrations are dependent on the climate, cultivation site and respective fruit variety (Feugang, et 
al., 2006).  Opuntia fruits are rich in polyphenolic compounds, namely flavonoids such as quercetin, 
kaempferol, isorhamnetin (Tesoriere (a), et al., 2005) and betalains, (Stintzing, et al., 2001). Betalains 
are nitrogen-containing  vacuolar  pigments  and  can  be yellow-orange (betaxanthins)  or  red-violet 
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(betacyanins). Recently, betalains have received much more interest due to their possible use as 
natural  food colorants in industry (Azeredo, 2009) . Opuntia fruits also contain vitamins E, K1  and C 
(Ramadan and  Morsel, 2003, Stintzing, et al., 2001), amino acids, especially proline and taurine 
(Stintzing, et al., 2001, Tesoriere, et al., 2005), minerals, namely calcium, potassium and magnesium 
(Gurrieri, et al., 2000, Lee, et al., 2005, Piga, 2004, Stintzing, et al., 2001) and sugars, such as glucose 
and fructose, (Galati, et al., 2003, Piga, 2004). 
As numerous fruits and vegetables, Opuntia fruits have been reported to be beneficial to 
health.  Recent  studies  reported  that  Opuntia  fruits  may  prevent  oxidative  stress  by  acting  as 
scavengers of free radicals (Butera, et al., 2002, Chavez-Santoscoy, et al., 2009, Galati, et al., 2003, 
Kuti, 2004, Tesoriere, et al., 2004). In particular, betalains have shown to be more potent antioxidants 
than ascorbic acid (Stintzing, et al.,  2005). The anticancer effect of Opuntia fruits extracts has also 
been reported in vitro using ovarian, cervical and bladder cancer cells and in vivo using a nude mice 
ovarian cancer model (Zou, et al., 2005). The antiproliferative effect of Opuntia was also reported in 
human cancer cells of gliobastomas (Hahm, et al.,  2010) and   leukemia (Sreekanth, et al., 2007). 
Additionally, Opuntia fruits have shown others beneficial effects such as antiulcerogenic (Galati, et 
al., 2003), antinflammatory  and  analgesic (Loro, et al., 1999). 
Due to the great number of potentially active nutrients and their multifunctional prop erties 
Opuntia  spp. fruits can be considered as perfect candidates for the production of health-promoting 
food and food supplements. 
 
 
1.4 Nutraceuticals and functional foods 
 
In the past few years, there has been an increase demand by consumers for health-promoting 
food products and two new concepts appear in the market: nutraceuticals and functional food. 
In 1989, a new hybrid term between nutrients and pharmaceuticals, "nutraceuticals", has been 
coined by Stephen DeFelice, MD, founder and chairman of the Foundation for Innovation in Medicine 
(Brower, 1998). Nutraceuticals can be found  in presentations similar to drugs (pills, extracts, tablets, 
etc) (Espín, et al., 2007)  and is defined as diet supplements that deliver a concentrated form of a 
presumed bioactive agent from a food  (Zeisel, 1999). 
Functional foods represents a type of food that when consumed regularly exert a specific 
health-beneficial effect (i.e., a healthier status or a lower risk of disease) beyond their nutritional 
properties, and this effect must be scientifically proven (Espín, et al., 2007). 
Some of the most common bioactive ingredients found in the nutraceutical and functional food 
market are polyphenols such as anthocyanins, proanthocyanidins, flavonols, stilbenes, 
hydroxycinnamates, coumarins, ellagic acid   and ellagitannins, isoflavones, lignans, etc. (Espín, et al., 
2007). Most of these compounds are isolated from natural sources using several extraction techniques. 
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1.4.1 Extraction methods 
 
In recent years, extraction, isolation and purification of phytochemicals from natural sources, 
provide business opportunities and offers additional environmental and economic incentives for food 
industry.  In  order  to  obtain  such  valuable  compounds,  extraction  techniques  have  been  widely 
investigated. For that, it is of critical importance to select efficient extraction procedure/method and 
maintain the stability of phenolic  compounds. Conventional solvent extractions (CSE) are the most 
commonly used procedures to prepare extracts from plant materials due to their ease of use, efficiency, 
and wide applicability (Dai and Mumper, 2010). The yield of chemical extraction depends on several 
factors such as the type of solvents, extraction time and temperature, sample/solvent ratio as well as on 
the chemical composition and physical characteristics of the samples (Dai and Mumper, 2010, Xu and 
Chang,  2007).  Organic  solvents,  such  as  methanol,  ethanol,   acetone,  ethyl  acetate  and  their 
combinations with water have been widely used for the extraction of phenolics from plant materials 
(Xu  and  Chang,  2007).  However,  due  to  the  low  selectivity  and  extraction  yields  (unwanted 
substances such as sugar, organic acids and/or fats may be also recovered) of CSE additional steps 
may be required to successful isolate the bioactive ingredients (Dai and Mumper, 2010).  Additionally, 
CSE employed large amounts of toxic solvents (Dai and Mumper, 2010) and longer extraction times 
Therefore nmerous others extraction methods have been proposed   such as: adsorption technology 
(AD)  (Soto, et al., 2011) microwave, ultrasound-assisted extractions, and techniques based on use of 
compressed fluids such as: supercritical fluid extraction (SFE) and pressurized liquid extraction (PLE) 
(Dai and Mumper, 2010). 
The adsorption technology (AD) is attractive for its relative simplicity of design, operation and 
scale up, high capacity and favorable rate, insensitivity to toxic substances, ease of regeneration and 
low cost. Additionally, it avoids using toxic solvents and minimizes degradation (Soto, et al., 2011). 
Adsorption is a  process of accumulation of molecules from a bulk solution onto the external and 
internal  surfaces  of  the  adsorbent.  This  process  involves  various  chemical  interactions  such  as 
hydrophobic, electrostatic attraction and hydrogen bonding. The sorption capacity of the adsorbents 
strongly  depends  on  the  surface  area,  contact  time,  polarity,  concentration  and  the  degree  of 
hydrophobicity  in  the  adsorption  system  (Barkakatia,  et  al.,  2010).  There  are  several  types  of 
adsorbents that can be used, including activated carbons, minerals and resins (Soto, et al., 2011). In 
particular, the use of resins (synthetic polymeric adsorbents with hydrophilic or hydrophobic nature) 
has  many  advantages,  such  as:  chemically  inert,  durable  and  stable,  high  adsorption  capacity, 
efficiency, selectivity and ease of regeneration, with relatively low cost and limited toxicity. 
Other technique with growing interest for extraction of phytochemicals is pressurized liquid 
extraction (PLE) (or accelerated solvent extraction (ASE) or pressurized fluid extraction (PFE)) , and 
it partly derives from supercritical fluid extraction (Camel, 2001) . In this technology carbon dioxide 
can be used in combination with water and/or an alcohol (forming a gas-expanded liquid) to extract 
pytochemicals  (Seabra,  et  al.,  2010).  The  combined  use  of  high  pressures  (3.3-20.3  MPa)  and 
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temperatures (40-200°C) provides faster and efficient extractions that require small amounts of classic 
solvents (Dai and Mumper, 2010). Moreover high pressure extraction has other advantages such as the 
fact that native  enzymes, which degrade phenolic compounds, are inhibited by extraction pressure 
increasing  and  CO2   addition.  Besides  that  supercritical  fluid  processed  materials  do  not  require 
additional sterilization steps (Seabra, et al., 2010). In recent years, PLE has been successfully applied 
to the extraction of phenolic compounds from different plant materials such as grape seeds and skin 
(Piñeiro, et al., 2006), apples  (Alonso-Salces, et al., 2001) spinach (Howard and Pandjaitan, 2008), 
and eggplants (Luthria and Mukhopadhyay, 2006). 
 
 
1.5 Aim and rational of the thesis 
 
This thesis focus on the evaluation of the bioactive effect of several Portuguese Opuntia fruits 
derived from two different species (O. ficus-indica and O. robusta) with potential application in colon 
cancer therapy. To achieve this, an integrated approach was developed by: i) investigating functional 
properties of Opuntia spp. fruit juices, and ii) developing and/or evaluating the anticancer activity of 
Opuntia spp. natural extracts. 
Within this context, the work was divided into three parts, as esquematly presented in 
 
figure 1.6. 
 
 
 
 
 
Figure 1.6. Structure of the thesis. 
 
 
 
In part 1, five Opuntia fruit juices were evaluated in terms of phenolic compounds and 
bioactivity in an effort to distinguish promising functional beverages. In part 2, the development of 
Opuntia natural extracts were performed by processing the most effective Opuntia juices and the most 
interesting  fruit   juice  residues  with  clean  technologies.  All  extracts  were  screened  for  their 
antiproliferative effect in HT29 cells and the most promising ones were further selected to be fully 
characterized in Part 3. In this part, the analysis of cell cycle distribution and ROS generation were 
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performed, in order to better understand the mechanisms underlying HT29 cell death. Additionally, a 
drug-resistant cell line (HT29 dx) was created to evaluate the chemosensitization effect of natural 
extracts. 
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2. Experimental procedure 
 
2.1 Chemicals 
 
EtOH  96%   (AGA,   Lisbon,   Portugal),   distillated   water   (ITQB,   Lisbon),   food  grade 
macroporous resin Amberlite XAD-16 (Sigma-Aldrich, St Louis, USA) and were used for extraction 
experiments. 
For phytochemical characterization: sodium carbonate (Na2CO3) were purchased from Sigma- 
Aldrich   (St  Quentin  Fallavier,  France),  Folin  Ciocalteau  reagent  was  acquired  from  Panreac 
(Barcelona, Spain)  and gallic acid was purchased from Fluka (Germany). Sodium nitrite (NaNO2) 
were from Riedel-de-Haën  (Seelze, Germany), aluminium chloride (AlCl3) and sodium hydroxide 
(NaOH)  was  obtained  from  Sigma-Aldrich,  in  Germany.  (+)-Catechin  hydrate  was  from  Sigma 
(Japan). 
 
Chemicals  used  for  antioxidant  activity  assays  were:  2‟,2‟-Azobis  (2-  amidinopropane) 
dihydrochloride (AAPH), 6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid (Trolox), caffeic 
acid  (C9H8O4),  cobalt  floride  tetrahydrate  (CoF2),  hydrogen  peroxide  (H2O2) and  picolinic  acid 
(C6H5NO2) were purchased from Sigma-Aldrich (St Quentin Fallavier, France). Disodium fluorescein 
(FL) was from TCI Europe (Antwerp, Belgium). Sodium chloride (NaCl), potassium chloride (KCl) 
and monopotassium phosphate (KH2PO4) were from Sigma-Aldrich (St Quentin Fallavier, France) and 
sodium phosphate dibasic dehydrate (Na2HPO4⋅2H2O) from Riedel-de-Haën (Seelze, Germany) were
 
used for phosphate buffer solution preparation (PBS). 
 
All cell culture media and supplements, namely fetal bovine serum (FBS), glutamine, RPMI 
 
1640 and trypsin/EDTA were obtained from Invitrogen (Gibco, Invitrogen Corporation, Paisley, UK). 
Moreover,   chemicals  used  for  cell-based  assays  were:  MTS  tetrazolium  compound  (3-(4,5- 
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) from Promega 
Corporation  (Madison,  USA),  dimethyl sulphoxide (DMSO) (99.5%, Panreac,  Barcelona,  Spain), 
ribonuclease A (Calbiochem, Darmstadt, Germany), 2‟,7‟- dichlorofluorescin diacetate (DCFH-DA), 
methylthiazolyldiphenyl - tetrazolium bromide (MTT), Triton X (C14H22O(C2H4O)n), propidium iodide 
(C27H34I2N4),  doxorubicin  hydrochloride  (C27H29NO11
.
HCl) ,  bovine  serum  albumin  (BSA)  and 
 
Bradford reagent all from Sigma-Aldrich (St Quentin Fallavier, France). PBS for cells was purchased 
from  Sigma-Aldrich  (St.  Louis,  USA)  and  CyQUANT  Cell  Proliferation  Assay  Kit  was  from 
Invitrogen (Carlsbad, California, USA). 
 
 
2.2 Opuntia spp. samples and fruit juices preparation 
 
Opuntia spp. fruits were collected in five different regions of Portugal, named Tramagal, Beja, 
Marvão,  Sines and Quarteira. The plants are grown without any agronomical inputs and fruits were 
harvested by hand during October 2010. 
Firstly, for sample preparation, spikes were removed with a brush and prickly pears were 
 
processed  in  a  food  processor  (UFESA,  LC5005,  China)  to  collect  the  fruit  juice  and  the 
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corresponding residue, which are mainly composed by hard seeds and part of the peel. Fruits juices 
were centrifuged (Avanti J26 XPI, Beckman Coulter®, California, USA) at 9000 rpm for 10 minutes 
and the supernatant was collected and filtrated in a 0.22 μm filter (Sarstedt, Nümbrecht, Germany). 
The resulting  juices and residues were separated and preserved under frozen storage (-20ºC) until 
analyses. 
 
 
2.3 Opuntia spp. extracts 
 
2.3.1 Opuntia spp. extracts from fruit juices: adsorption technology (AD) 
 
Opuntia juices were used for production of polyphenols-rich concentrates (PRCs) through 
adsorption technology. For that a food grade macroporous resin Amberlite XAD-16 was used. This 
resin is  allowed to food applications by the U.S. Food and Drug Administration Code of Federal 
Regulation Title 21 (Scordino, et al., 2003). Before the experimental procedure it was necessary the 
resin preconditionation.  This was realized by an extensive wash of the resin with distilled water to 
remove salts and impurities as described by Serra (2010). Then the resin was dried for 24 h at 70ºC 
and cooled in desiccators and further immersed in ethanol (96%). After 12 h later ethanol was replaced 
by distilled water through washing. Once prepared to use, Opuntia spp. juices were put in contact with 
resin XAD-16 inside flaks (equivalent to 30 mg of polyphenols/g of resin). These flaks were protected 
from light and submitted to an agitation at 200 rpm for 4 h. Afterwards the supernatant were removed 
and resins were washed three times with distilled water in order to remove water soluble constituents 
(i.e. sugars, organic acids and minerals). Polyphenols were recovered from resins in the elution step 
with ethanol (96%). The ethanolic fractions were vacuum filtered through one layer  of filter pa per 
(Filter-lab, Barcelona, Spain) and concentrated in a rotary evaporator (BUCHI Rotavapor  R-210, 
Flawil,  Switzerland)  under  reduced  pressure  at  40ºC  (BUCHI  Heating  Bath  B-491,  Flawil, 
Switzerland). Finally, extracts were transferred into a water phase and freeze dried (Modulyo freeze 
dried, Eduards, Sussex, UK)  at -20ºC, in the absence of light, during 48h. The resulting PRCs were 
kept in a cool, dry and dark environment until analyses. The final extracts were designated as PRCs 
according with sample origin (Quarteira, Sines and Tramageal). 
 
 
2.3.2  Opuntia  spp.   extracts   from  fruit  juices  residues:  Conventional  solvent 
extraction (CSE) 
Opuntia fruits residues from Sines, Quarteira and Beja were extracted using CSE under the 
conditions described below. 
Opuntia fruits residues from Sines and Quarteira were extracted in the dark with EtOH:H2O 
(50:50 v/v) solution (1:20, w/v), for 2 h at room temperature in constant agitation (IKA® dual-speed 
mixer RW 20.n,  Aldrich, St. Luis, USA). The extracts were then centrifuged at 9000 rpm for 10 
minutes and the  supernatants were concentrated in a rotary evaporator (BUCHI Rotavapor R -210, 
Flawil, Switzerland) in a water bath at 40ºC and under reduced pressure, in order to remove ethanolic 
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fraction.  The final  extracts  were designated as  Q1 (from Quarteira  residue) and S1  (from Sines 
residue). 
Opuntia residue from Beja was extracted in a 1:20 (w/v), for 2 hours, in the dark, at room 
temperature in constant agitation (IKA® dual-speed mixer RW 20.n, Aldrich, St. Luis, USA) using 
different solutions: i) 100% EtOH; ii) 100% H2O; iii) 60%EtOH:40%H2O and iv) 70%EtOH:30%H2O. 
The extracts were then filtered, centrifuged at 9000 rpm for 10 minutes and the supernatants were 
concentrated in a rotary evaporator in a water bath at 40ºC under reduced pressure. Finally, extracts 
were freeze dried (Modulyo  freeze  dried, Eduards, Sussex, UK) at -20ºC, in the absence of light, 
during   48h.   The   final   extracts   were   designated   as   A   (100%   EtOH),   B   (100%   H2O)   C 
(60%EtOH:40%H2O) and D (70%EtOH:30%H2O). 
 
 
2.3.3 Opuntia spp. extracts from fruit juices residues: adsorption technology (AD) 
Conventional extracts obtained from Quarteira and Sines fruit juice residues (Q1 and S1) were 
submitted to adsorption technology using the adsorbent Amberlite XAD-16 resin. The experimental 
procedure was the same as described for fruit juices (section 2.3.1). The final extracts were designated 
as Q2 and S2. 
 
 
 
 
(PLE) 
2.3.4 Opuntia spp. extracts from fruit juices residues: Pressurized liquid extraction 
 
Pressurized solvent  extracts from Opuntia ficus-indica fruit residue from Beja were kindly 
provided by Dr. Hermínio de Sousa and his laboratory team group (Laboratory of Polymer Processing 
and Supercritical Tecnology, Universidade de Coimbra, Portugal). Ten extracts obtained at 313K and 
20MPa and using diverse CO2/EtOH/H2O mixtures were provided (table 2.1). 
 
 
Table 2.1. Extracts obtained from Beja residue using PLE technology 
 
 
Sample ID 
Molar fracctions 
EtOH CO2 H2O 
1 1 0 0 
2 0.4 0.6 0 
3 0.4 0 0.6 
4 0.7 0.3 0 
5 0.4 0.3 0.3 
6 0.7 0 0.3 
7 0.8 0.1 0.1 
8 0.5 0.4 0.1 
9 0.5 0.1 0.4 
10 0.6 0.2 0.2 
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2.4 Phytochemical characterization 
 
2.4.1. Polyphenols 
 
Total phenolic content by Folin Ciocalteau method 
 
Total concentration of phenolic compounds present in Opuntia spp. extracts were determined 
according to the Folin Ciocalteau colorimetric method (Singleton and Rossi, 1965) as described by 
Serra (2010). Briefly, 20μL of the appropriate dilutions of Opuntia samples were added to 1580μL of 
distilled water  and oxidized with 100 μL of Folin Ciocalteau reagent. The reaction was neutralized 
with 300 μL of sodium  carbonate solution (Na2CO3) and incubated at 40ºC for 30 minutes.   The 
absorbance of samples were measured at 765 nm in a spectrometer (Genesys10uv, Thermo Spectronic, 
New York, USA) and gallic acid was used as standard (0-800 mg/L) for the calibration curve. The 
results were expressed as means of triplicates  (mg of gallic acid equivalents per gram of extract - 
mgGAE/g). 
 
 
HPLC analysis 
 
HPLC analysis of Opuntia spp. juices were performed by Analytical Group of IBET (Oeiras, 
Portugal)  coordinated by Dr. Rosário Bronze. Briefly the analysis were performed on a Waters
® 
Alliance 2695 (Waters) equipped with a quaternary pump, solvent degasser, auto sampler and column 
oven, coupled to a Photodiode Array Detector Waters 996 PDA (Waters). A pre-column (RP-18, 5µm) 
and reversed phase column (RP-18 Synergy, 2.5 m Max-RP from Phenomenex) with oven at at 35ºC 
were used for separation. The gradient mobile phase consisted of 0.5% formic acid p.a in ultra pure 
water (A): LC-MS grade acetonitrile (B) at a flow rate of 0.30 mL/min. Total polyphenol content of 
fruit juices were assayed using acid gallic as standard. Solutions of 5, 20, 40, 60, 80 and 100 ppm of 
gallic acid were used for calibration curve. Results were expressed as mg GAE/ L of juice fruit. 
Identification of polyphenol compounds was done by HPLC/MS. A triple quadrupole mass 
spectrometer MicroMass
®   
Quattro micro (Micromass, Waters) outfitted with electrospray ionization 
source  (ESI) was used in tandem at temperature of 120ºC and capillary voltage of 3.0 kV. The 
compounds were ionized in both negative and positive ion mode and spectra of the column elute were 
recorded in the range m/z 100-1000. High purity nitrogen (N2) was used both as drying gas and as a 
nebulising gas. Ultrahigh-purity Argon (Ar) was used as collision gas at a pressure of 1×10
-4  
mBar. 
 
MassLynx software was used for data acquisition and processing. 
 
 
 
2.4.2 Flavonoid content 
 
The measurement of flavonoid content was performed by the AlCl3   complexation method 
described by (Zhishen, et al., 1999) modified for the reader microplate (Powerwave XS Microplate 
Spectrophotometer, Biotek Instruments, Winooski, USA) according to Tavares, et al., 2010 . To each 
well of a 96-well microplate was added 125 μL of distilled water, 25 μL of Opuntia spp. fruit juice and 
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7.5 μL of NaNO2  5% (w/v). The mixture was allowed to stay at room temperature and after 6 minutes 
were added 15 μL of AlCl3  10% (w/v). After 5 min of incubation, 100μL of NaOH (1M) was added 
and the solution of each well was mixed by pippetting up and down. The absorbance was measured at 
510 nm.  (+)-Catechin  hydrate,  minimum  98%  (w/w)  was  used  as  standard,  and  the results  are 
expressed as mg catechin equivalents per L of juice (mg CE/L). 
 
 
2.5. Antioxidant activity 
 
2.5.1 Oxygen radical absorbance capacity (ORAC) 
 
ORAC assay was carried out by following the method previously described (Huang, et al., 
 
2002) modified for the FL800 microplate fluorescent reader as described by Serra et al., 2010. This 
assay measures the ability of the antioxidant species present in the sample to inhibit the oxidation of 
disodium fluorescein (FL) catalyzed by peroxyl radicals generated from AAPH. 
Briefly, in a 96-well microplate were added 25 µL of the appropriate sample dilution and 150 
 
µL of disodium fluorescein (2×10
−7 
mM). The microplate was put in a fluorescent reader and allowed 
to incubat at 37ºC, for 10 minutes. The reaction was started with 25 µL of AAPH (153 mM) added 
through the  injector. Fluorescence emitted by the reduced form of FL was measured in an FL800 
microplate fluorescent reader (Bio-Tek Instruments, Winooski, VT, USA) and recorded every 1 min at 
the emission wavelength of 530±25 nm and excitation wavelength of 485±20 nm for a period of 30 
min. Phosphate buffer (75 mM, pH=7.4) was used to prepare AAPH and FL solutions and was used as 
blank. Solutions of 5, 10, 20, 40, and  50 μmol/L of Trolox  were used as control standards. All 
samples, including the blank and the controls, were analyzed as triplicates. Final ORAC values were 
calculated by a regression equation between the Trolox concentration and the net area under the FL 
decay curve and were expressed as Trolox Equivalents per litre of  Opuntia juice or gram of extract 
(μmol TE/L of juice or μmol TE/g of extract). 
 
 
2.5.2 Hydroxyl Radical Adverting Capacity (HORAC) 
 
HORAC assay was based on a previously reported method (Ou, et al., 2002), modified for the 
FL800  microplate fluorescence reader (Bio-Tek Instruments, Winooski, VT, USA) as described by 
Serra et al.,  2010. This assay evaluates the hydroxyl radical prevention capacity of a sample using 
fluorescein (FL) as the probe. The hydroxyl radical was generated by a Co(II)-mediated Fenton like 
reaction and, similarly to ORAC assay, the fluorescence decay curve of FL was used to quantify the 
HORAC value. Briefly, 10 µL of appropriate dilutions of samples were added to 180 µL of FL (4x10
-3
 
µM) in a 96 well microplate. After 10 minutes of incubation at 37ºC were added 10µL of H2O2  (0.55 
 
M). The reaction was started with 10 µL of CoF2  added through the injector. Fluorescence emitted by 
the reduced form of FL was measured and recorded every 1 minute during 35 minutes. The FL800 
microplate fluorescence reader was used with fluorescence filters for an excitation wavelength of 
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485±20 nm and an emission wavelength of 530±25 nm. Caffeic acid was used as a standard and 100, 
 
200, 300, 400, 600 µM solutions in PBS were used to perform the calibration curve. Data was 
expressed as micromoles of caffeic acid equivalents (CAE) per litre of juice or g of extract and all 
samples were analyzed as triplicates. 
 
 
2.6. Cell-Based Assays 
 
2.6.1 Cell culture 
 
Human colon cancer cell lines, HT29 and Caco2, were obtained from American Type Culture 
Collection (ATCC, USA) and Deutsche Sammlung von Microorganismen und Zellkulturen 
(Barunshweig,Germany),   respectively.   Both   cell   lines   were   grown   in  RPMI   1640   medium 
supplemented with 10% of fetal bovine serum (FBS) and 2  mM of glutamine. Stock cells  were 
maintained  as  monolayers  in  175  cm
2    
culture flasks  and  incubated  at  37ºC  with  5%  CO2    in  a 
humidified atmosphere. All  cell culture media  and  supplements  were obtained from Invitrogen 
(Gibco, Invitrogen Corporation, Paisley, UK). 
 
 
2.6.2 Citotoxicity assay 
 
Citotoxicity assays of Opuntia spp. samples were performed using completely differentiated 
Caco2 cells which were obtained from a human colon adenocarcinoma and are a good model of the 
intestinal barrier. This cell line undergoes in culture a process of spontaneous differentiation that leads 
to  the  formation  of  a   monolayer  of  cells,  expressing  several  morphological  and  functional 
characteristics of the mature enterocyte (Sambuy, et al., 2005). 
The assay was performed as described by Serra 2010. Briefly, cells were seeded at a density of 
 
2x10
4   
cells/well in 96 well microplate and the medium was changed every 48 h. After confluence 
(about 72 h after seeding), Caco2 cells were incubated with different concentrations of Opuntia spp. 
samples diluted in culture medium (RPMI medium with 0.5% FBS and 2mM glutamine). Control cells 
were performed with 100% of RPMI 1640 medium or a mixture of sample solvent and medium. After 
24, 48, 72 or 96 hours of incubation, the citotoxicity was analyzed using cell viability assays such as 
Cell  Titter® AQueous One Solution Cell Proliferation Assay and CyQUANT® Cell Proliferation 
Assay Kit (see  appendix  A). Results  were calculated in terms  of percentage of cellular viability 
relative to control (%). Experiments were performed in triplicate and results were expressed in terms 
of % of cellular viability relative to control. 
 
 
2.6.3 Antiproliferative assay 
The antiproliferative activity of Opuntia spp. samples was assayed on human colon carcinoma 
cells, HT29, which are a widely used model for in vitro colorectal cancer studies. 
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The assay was performed as described previously (Serra, 2010). Briefly, cells were cultured in 
 
96-well microplates at a density of 1x10
4   
cells/well. After 24 hours incubation at 37ºC in 5% CO2 
atmosphere, the medium of each well was removed and cells were incubated with Opuntia samples 
diluted in RPMI medium with 0.5% FBS. After 24, 48, 72 or 96 hours the medium was remove and 
the cell viability  was determined using commercially available assay kits, such as colorimetric Cell 
Titter® AQueous One Solution Cell Proliferation Assay or CyQUANT® Cell Proliferation Assay Kit 
(see appendix A). Results were expressed in terms of % of cellular viability relative to control (cells 
without Opuntia samples). Additionally  the amount  of sample necessary to decrease 50% of the 
cellular  viability,  ED50  (Effective  Dose),  was  calculated  through  concentration  logarithm.  The 
experiment was performed in triplicates. 
 
 
2.6.4 Cell Cycle analysis 
 
Cell cycle analysis was performed as described by Serra (2010) with some modifications. 
Briefly, HT29 cells were seeded in 25 cm
2  
culture flasks at a density of 1,96x10
5  
cell/flask. After 24 
hours, cells were treated with Opuntia extracts diluted in culture RPMI medium (0.5% FBS and 2mM 
glutamine) for 24, 48 or 72 hours. Control cells were performed using culture medium alone or with 
the sample solvent. After incubation  time, cells  were detached with 1  mL of trypsin/EDTA and 
resuspended in 1 mL of RPMI medium (0.5% FBS) and centrifuged at 200 g (Mikro 220R, Hettich, 
Tuttlingen, Germany) for 10 minutes. Then, cells were washed with cold PBS and centrifuged again 
(200 g) for 10 minutes. Afterwards, supernatant was discarded  and 1 mL of a solution containing 
propidium  iodide (50  mg/L),  1.5% Triton  –  X (1.5%),  ribonuclease A  (0.700  U/mL) and NaCl 
(0.01M) was added to 1x10
6
cells. Cell suspensions were incubated for 2 hours at room temperature 
and then  at  4ºC  overnight.  The samples  were sorted by flow cytometer  CyFlow Space  (Partec, 
Germany) and cell cycle analysis was done with FlowMax cell cycle platform (Partec, Germany). 
 
 
2.6.5 Detection of ROS generation 
 
Intracellular ROS level were determined in HT29 cultured cells using the method described by 
(Wolfe  and Liu, 2007) with some modifications. HT29 cells were seeded in a 96-well microplate 
(1x10
4 
cells/well) in RPMI medium (10% FBS and 2 mM glutamine) and allowed to incubate at 37ºC 
in a 5% CO2  atmosphere. After 24 hours the medium was replaced by 0.5 mg/ml of Opuntia extracts 
and incubated for more 24 hours. Controls were performed with RPMI medium only. After incubation, 
Opuntia extracts were removed and cells were washed with PBS. After that 100 µL of DCFH-DA (25 
µM) was added to each well and cells were incubated for 10 minutes. Fluorescence were measured 
(excitation  492  nm;  emission  540  nm)  using  a  FL800  microplate  fluorescent  reader  (Bioteck 
Instruments,  USA).  The  experiment  was  performed  in  triplicates  and  results  were  presented  in 
percentage of fluorescence intensity relatively to the control. 
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2.6.6 Chemosensitization effect 
 
2.6.6.1 Development of a subpopulation drug-resistant (HT29-dx) 
 
A subpopulation of HT29 cells, named HT29 dx, was created according to the method of 
Riganti et  al., 2005. Briefly, HT29 cells were cultured in RPMI medium (10% FBS and 2 mM of 
glutamine) supplemented with 68 nmol/L of a common chemotherapeutic drug (doxorubicin) during 
20 to 25 passages. After that HT29 cells were subsequently cultured in RPMI medium containing 34 
nmol/L of doxorubicin as "maintenance dose". 
 
 
2.6.6.2 Cellular sensitivity to drug 
 
Cellular sensitivity to doxorubicin was evaluated by growth-inhibition assay after 1 hour of 
drug exposure, according to the method previously described (Ravizza, et al., 2004). Briefly, HT29 
and HT29-dx cells were seeded onto 96-well microplates (1x10
4  
cells/well) and allowed to grow for 
24 hours prior to treatment. Then, the medium was removed and several concentrations of doxorubicin 
were added (0.16-20 µM) in each cell line, for 1 hour. After exposure, doxorubicin was removed; cells 
were washed with PBS and incubated with RPMI medium (10% FBS and 2 mM glutamine). After 72 
hours  of  incubation,  cell  growth inhibition  was  assayed by the MTT assay  (Supino,  1998)  (see 
appendix A). Experiments were performed in triplicate and results were expressed in terms of % of 
cellular viability relative to control. 
 
 
2.6.6.3 Intracellular doxorubicin accumulation 
 
The intracellular doxorubicin accumulation in HT29 and HT29 dx cells  were determined 
according to the method described previously (De Boo, et al., 2009). Both cell lines were seeded in 25 
cm
2  
culture flasks at a density of 1.46x10
5  
cell/flask in RPMI medium (10% FBS). After 24 hours the 
medium  was  removed  and  cells  were washed  twice with PBS  and  incubated  in RPMI  medium 
(without phenol red) containing 5 μmol/L doxorubicin. Controls were performed with RPMI medium, 
only. After 24 hours, cells were washed twice with PBS and detached with 2 mL of trypsin/EDTA. 
The cells were centrifuged for 30 seconds at 13000 g (Mikro 220R, Hettich, Tuttlingen, Germany) and 
resuspended in 1 mL of a 1:1 mixture of ethanol/0.3 N  HCl. Cells were disrupted with cycles of 
thawing  and  heating.  The protein  content  of  cell  lysates  was  measured  through  Bradford  assay 
(Bradford, 1976) and the amount of intracellular doxorubicin was detected using a FL800 microplate 
fluorescent reader (Bioteck Instruments, USA) at excitation and emission wavelengths of 475 and 553 
nm, respectively. A blank was prepared in the absence of cells in each set of experiments  and  its 
fluorescence was subtracted from that measured in each sample. Fluorescence was converted in ng 
doxorubicin/mg cells proteins using a calibration curve previously prepared. 
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2.6.6.4 Chemosensitization activity 
 
The effect of Opuntia extracts in combination with doxorubicin on HT29 and HT29 dx cells 
growth  was assessed by the MTT assay (see appendix A). Briefly, cells were seeded in 96-well 
microplate (1x10
4  
cells/well) and allowed to grow for 24 hours. Three different treatment schedules 
were used a) 24h RPMI medium, 1h doxorubicin (5-20 µM) followed by 72 h incubation in drug-free 
medium; b) 24 h of  Opuntia extract (9 and 6 mg/ml for Q1 extract and 12 and 9 mg/ml for extract 2 of 
PLE ) followed by 72 h incubation in drug-free medium; c) 24 h of Opuntia extract (9 and 6 mg/ml for 
Q1 extract and 12 and 9 mg/ml for extract 2 of PLE) followed by 1 h doxorubicin (5-20 µM) and 72 h 
incubation in drug-free medium. Results were expressed in terms of % of cellular viability relative to 
control. 
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Sample ID Opuntia specie Fruit juice color TPC1  (mg GAE/L) TFC2  (mg CE/L) 
Tramagal  
 
Opuntia ficus- 
indica 
Dark yellow 409.4 86.2 
Beja Yellow 337.1 220.2 
Marvão Orange-red 384.5 158.4 
Sines Dark yellow 494.3 79.6 
Quarteira
* Opuntia robusta Purple 45.0 80.0 
 
3. Results and discussion 
 
Opuntia spp. fruits were harvested in Portugal from five different regions, namely Tramagal, 
Beja, Marvão, Sines and Quarteira and were processed and separated into juice and residue. 
Firstly,  Opuntia  spp.  juices  were  characterized  in  terms  of  phytochemical  composition, 
antioxidant activity and antiproliferative effect on human colon cancer cell line (section 3.1- Part 1). 
Then, the most effective juices and the most interesting residues were processed by clean technologies 
for the developed  functional ingredients (section 3.2. - Part 2). All extracts were screened for their 
antiproliferative effect and the most promising ones wer e further selected to be fully characterized 
(section 3.3 – Part 3). 
 
 
3.1 PART 1 - Looking for anticancer activity in Opuntia spp. juices 
 
3.1.1 Phytochemical characterization 
 
In this work two different species of Opuntia spp., namely O. ficus-indica and O. robusta were 
analyzed. The main morphological difference between the fruits of these two species is related with 
the spikes: O. ficus-indica have smaller spikes than O. robusta (figure 3.1). Concerning the juices, the 
color of samples varied  according with fruit origin (table 3.1 and figure 3.2). Additionally, it was 
noted that O. robusta pulp juice fruit is more viscous than O. ficus-indica. 
 
 
 
 
Figure 3.1. Opuntia spp. fruits from: A) O. robusta (Quarteira) and B) O. ficus-indica (Marvão). 
 
 
Table 3.1. Opuntia spp. fruits varieties, color juice and phytochemical characterization. 
 
 
 
 
 
 
 
 
 
 
*All fruits were processed with peel, except O. robusta 
1  TPC: Total Polyphenolic Content; 2 TCF: Total Flavonoid Content 
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Figure 3.2. Opuntia spp. fruit juices from Tramagal, Beja, Marvão, Sines and Quarteira. 
 
 
 
In  a  first  approach,  Opuntia  juices  were analyzed  for  their  content  and  composition  of 
bioactive compounds. For that HPLC was used to identify the main phenolic compounds as well as to 
quantify the total  content. Additionally, the total flavonoid concentration was determined using a 
colorimetric assay. As  shown  in table 3.1, the five Opuntia juices present different phytochemical 
content. The total phenolic content ranged from 45 to 494 mg GAE/L and flavonoid between 80 and 
220 mg CE/L, which is in accordance with the literature (Chavez-Santoscoy, et al., 2009, Kuti, 2004, 
Stintzing,  et al., 2005). When compared with other beverages O. ficus-indica has a polyphenol total 
content similar to some types of teas (i.e. cammolmile, lemon thyme and black tea) and orange and 
apple juice (Neveu, et al., 2010, Seeram, et al., 2008). Among all samples, the fruit juices from Sines 
and Tramagal presented higher phenolic content whereas the sample from Beja contained the highest 
flavonoid concentration. Moreover, it is important to note that flavonoid concentrations varied within 
the juices of the same specie (Opuntia ficus-indica) and this is in agreement with previously works 
(Kuti, 2004). Despite that, there are some  reports where flavonoid content is much lower than the 
values reported in this work for O. ficus-indica (Fernández-López, et al., 2010, Kuti, 2004, Tesoriere, 
et al., 2005). This result could be related with the part of fruit used for making the juice. In this work 
O. ficus-indica samples were processed with the peel whereas the other authors used the fruit pulp 
only.  This  justification  is  in  accordance  with  data  reported  in  literature  related  with  phenolic 
composition of the peel and pulp of several fruits (Tomás-Barberán, et al., 2001). Phenolics might tend 
to accumulate in the dermal tissues of plant body due to their potential role in protection against UV 
radiations, acting as attractants in fruit dispersal, and as defense chemicals against pathogens  and 
predators (Tomás-Barberán, et al., 2001). 
Among  all  fruit   juices,   the  sample  from   Quarteira   (O.robusta)   showed  the   lowest 
concentrations  in  phenolic  compounds  which  could  be  related  with  the  fact  that  this  fruit  was 
processed without peel. Moreover, this Opuntia specie is already recognized to have lower phenolic 
content than Opuntia ficus-indica (Chavez-Santoscoy et al., 2009). 
In order to analyzed and compare the polyphenol composition of samples HPLC was performed 
 
at different UV absorptions, namely 280nm, 360nm, 480nm and 535nm which are the  characteristic 
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wavelength of phenolic compounds,  flavonoids,  betaxanthin (yellow-orange pigment) and betacyanin 
(red-purple pigment), respectively. As show in figure 3.3 Opuntia juices presented different phenolic 
content  and  composition. Some  compounds  were  identified  including:  citric  acid,  gallic  acid, 
isorhamnetins (isorhamnetin-3-O-rhamnose-lyxose-glucose, isorhamnetin-3-O-rutinoside, 
isorhamnetin-3-O-lyxose-glucose)   and   some   betaxanthin   and   betacyanin   pigments   (betalain 
indicaxantin and leucine-bx). The difference between O. ficus-indica and O. robusta species is evident 
in all  chromatographic profiles.   Moreover, fruit juice from Marvão distinguished from the others 
Opuntia ficus-indica juices for the presence of betaxanthin and betacyanin pigments. 
 
 
 
 
Figure 3.3.  Chromatograms  profiles  of  Opuntia  spp.  juices:  Tramagal,  Beja,  Marvão,  Sines  and 
Quarteira at A) 280nm, B) 360nm, C) 480nm and D) 535nm. Legend: 1- citric acid, 2 – gallic acid, 3- 
isorhamnetin-3-O-rhamnose-lyxose-glucose, 4- isorhamnetin-3-O-lyxose-glucose, 5- isorhamnetin-3- 
O-rutinoside, 6- isorhamnetin, 7- indicaxantin, 8- leucina-bx. 
 
 
 
3.1.2 Antioxidant activity 
 
In order to evaluate the antioxidant activities of Opuntia spp. juices, two different assays were 
performed: ORAC and HORAC. The ORAC assay analyzes the potential to scavenge harmful oxygen 
reactive species, namely peroxyl, while HORAC assay measures the efficacy of the sample to prevent 
hydroxyl radical formation. ORAC and HORAC values obtained for Opuntia spp. juices range from 
9949 to 33449 µmol TE/L and 9224 and 18285 µmol CAE/L, respectively (figure 3.4). 
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Figure 3.4. Antioxidant capacity (ORAC and HORAC values) of Opuntia spp fruit juices varieties. 
 
 
Tramagal and Sines juices were the varieties that presented the highest ORAC and HORAC 
values  while O.robusta juice from Quarteira showed the lowest result. It is important to note that 
ORAC values of  O.ficus-indica samples are higher than those previously reported by other authors 
(Chavez-Santoscoy, et al.,  2009, Kuti, 2004), probably due to the inclusion of the peel in the juice. 
When compared with other products, Portuguese O. ficus-indica juices have similar ORAC value as 
red wine, concord grape, blueberry juice and black cherry and contain at least a twice higher ORAC 
value that orange, apple, and black, green and white iced tea (Seeram, et al., 2008). 
Concerning HORAC results, this is the first report where this values are presented for Opuntia 
spp. It is important to note that the antioxidant activity is mainly related with the phenolics present in 
the  juice.  In  fact,   high  correlations  were  obtained  for  total  phenolic  composition  and  ORAC 
(R
2
=0.944) and HORAC assay (R
2  
= 0.742). 
 
 
3.1.3 Antiproliferative effect 
 
In order to evaluate the anticancer potential of Opuntia spp. juices, antiproliferative assay 
were performed using a human colon cancer cell line (HT29). Cells were exposed to Opuntia juices 
for 24, 48, 72  and 96 h and cell viability was evaluated using MTS assay. Since the inhibition of 
cancer cell growth was much more effective after 96 hours of exposure, the antiproliferative effect of 
all Opuntia juices were compared at that time. Dose-dependent curves are presented in figure 3.5. 
Results showed that juices from Tramagal and Sines had the highest antiproliferative effect on 
human colon cancer cells. This result could be related with the highest content in polyphenols and 
antioxidant activity. The amount of sample necessary to decrease 50% of the cellular viability (ED50) 
was also determined and Tramagal proved to be the most effective in inhibiting cancer cell growth 
(sample with the lowest ED50 value) followed by Sines juice (table 3.2). 
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Figure 3.5. Antiproliferative effect of Portuguese Opuntia spp. juices on human colon cancer cells (HT29) 
(incubation time: 96 hours). 
 
 
Surprisingly,  the juice obtained from O.  robusta  fruit  (Quarteira),  which  is  the one that 
showed lowest content in polyphenols and antioxidant effect, was the third most effective in inhibiting 
HT29 cell growth. This result suggests that there are some compounds in this juice that contribute to 
this effect. Comparing with Tramagal and Sines juices, chromatograms profiles of Quarteira at 480nm 
and 535 nm show the presence of  several compounds from betalains family. There are reports that 
suggest the anticancer effect of betalains,  namely the betacyanin (red-purple pigment) that showed 
anticancer effect on  Human Chronic Myeloid Leukemia Cell Line-K562 (Sreekanth, et al., 2007). 
 
 
Table 3.2. The amount of sample necessary to decrease 50% of the cellular viability (ED50) after 96 h of 
Opuntia juice exposure to HT29 cell line. 
Opuntia spp juice ED 50 (ml/ml) 
Tramagal 0.058 ± 0,01 
Beja ˃ 0.2 
Marvão ˃ 0.2 
Sines 0.075 ± 0.02 
Quarteira 0.12 ± 0.01 
 
 
Moreover, it is important to note that no Opuntia ficus-indica juices showed cytotoxic on 
Caco2 cell model. However, the juice from Quarteira showed some cytotoxicity after 96h of treatment. 
The half maximal inhibitory concentration (IC50) was determined and Quarteira juice is cytotoxic at 
high concentrations (IC50 = 0.17 ml/ml). 
Until now, this is the first report concerning the antiproliferative effect of Opuntia juices 
against HT29 cell line. Opuntia spp. fruit extracts and juices are already reported to inhibit the growth 
of other cancer cell lines derived from human cervical, ovarian, bladder, prostate, hepatic, colon and 
mammary cancer (Chavez-Santoscoy, et al., 2009, Zou, et al., 2005) 
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3.2 PART 2: Development of functional ingredients from Opuntia spp. and screening of their 
anticancer effect 
In this part of the work, the efforts were directed to develop promising anticancer Opuntia 
 
extracts that can be used as natural ingredients in chemotheraphy and chemopreventation of colon 
cancer.  The  use  of  different  extraction  methods  such  as  conventional  solvent  extraction  (CSE), 
adsorption  technology (AD) and pressurrized liquid extraction (PLE) was explored and applied to 
different raw  material: Opuntia juice fruits and residues.  All extracts were analyzed in terms  of 
phytochemical content,  antioxidant activity and antiproliferative effect in order to select the most 
promising ones. 
 
 
3.2.1 Extracts from Opuntia spp. juices: adsorption technology (AD) 
 
In order to obtain polyphenol-rich concentrates (PRCs) with anticancer properties, the most 
effective Portuguse Opuntia spp. juices, namely  Tramagal, Sines and Quarteira, were selected and 
processed  with  macroporous  adsorption  resin  Amberlite  XAD16,  as  described  in  experimental 
procedure (section 2.3.1). The products obtained were analyzed for their phytochemical composition, 
antioxidant capacity and antiproliferative effect on HT29 cell line. 
 
 
3.2.1.1 Phytochemical and antioxidant characterization 
 
Figure 3.6 shows the total phenolic content of PRCs from the three Opuntia spp. juices.  As it 
can be see, PRC-Sines presented the highest polyphenolic content. When compared with the juices, all 
PRCs have a much higher phenolic content (Table 3.3).  This improvement was approximately 38, 42 
and 318 times for Tramagal, Sines and Quarteira samples. 
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Figure 3.6. Total polyphenol content (mg GAE/g dry weight) of Sines, Quarteira and Tramagal PRCs. 
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Table 3.3. Total polyphenol content (mg GAE/dry weight) of PRCs and juices. 
 
 
 
Sample ID 
PRCs Juices   
Concentration factor 
(PRCs/juices) 
 
 
TPC (mg GAE/g dry weight) 
Tramagal 107.1 ± 2.5 2.80 38 
Sines 161.3 ± 5.1 3.84 42 
Quarteira 114.6 ± 6.3 0.36 318 
 
 
Chromatograms  profiles  obtained  at  280,  360,  480  and  535nm  show  different  phenolic 
composition (figure 3.7). Results showed that piscidic acid is the main phenolic acid present in 
Quarteira and Sines PRC samples (figure 3.7A). At 360 nm (figure 3.7B) it is show the absence of 
flavonoids in PRC-Quarteira. Furthermore, betaxanthin compounds were identified in both PRC-Sines 
and PRC-Quarteira samples (figure 3.7C), whereas betacyanin pigments were only present in the last 
one (Figure 3.7D). 
 
 
 
 
Figure 3.7. Chromatograms of Opuntia PRCs from Tramagal, Sines and Quarteira (1mg/mL) at (A) 280nm, (B) 
360 nm, (C) 480nm and (D) 535 nm. Legend: 1 – piscidic acid. 
 
The antioxidant capacity of PRCs was evaluated by ORAC and HORAC assays. Table 3.4 
shows that PCRs present higher antioxidant activity than Opuntia juices, and this difference is more 
pronounced in the ORAC value.  As verified for total polyphenolic content, PRC-Sines had the highest 
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antioxidant  activity  (see  figure 3.8).  This  result  was  expected  because  phenolic  compounds  are 
 
recognized as potent antioxidants. 
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Figure 3.8. Antioxidant capacity (ORAC and HORAC assays) of PRCs (Sines, Tramagal and Quarteira). 
 
 
Table 3.4. Anitoxidant capacity (ORAC and HORAC) of juices and its PRCs. 
 
  
ORAC (µmol TE/g dry weight) 
 
HORAC (µmol CAE/g dry weight ) 
Sample 
ID 
 
Juices 
 
PRCs 
Concentration 
factor 
 
Juices 
 
PRCs 
Concentration 
factor 
 
Tramagal 
228.9 ± 
15.7 
1011.1 ± 
61.9 
 
4 
94.8 ± 
12.9 
251.5 ± 
24.2 
 
3 
 
Sines 
257.1 ± 
16.5 
4164.5 ± 
209.3 
 
16 
142.2 ± 
13.6 
872.5 ± 
76.1 
 
6 
 
Quarteira 
79.7 ± 
10.2 
1786.3 ± 
144.76 
 
22 
73.9 ± 
10.0 
571.3 ± 
41.6 
 
8 
 
 
3.2.1.2 Antiproliferative effect and cell cycle analysis 
 
The next step of this work was to evaluate the antiproliferative effect of PRCs and select the 
most promising extracts for cell cycle distribution analysis. 
The antiproliferative activity was evaluated in HT29 cell line, after 72 hours of Opuntia PRCs 
treatment (1-6 mg PRCs/mL). As shown in figure 3.9, PRC-Sines and PRC-Quarteira presented higher 
antiproliferative  effect on HT29 cells. These results were expected because these two extracts had 
higher concentration of polyphenols and antioxidant effect, as reported above. 
 
 
 
 
 
 
 
 
 
 
 
34 
C
el
l 
v
ia
b
il
it
y
 (
%
 o
f 
co
n
tr
o
l)
 
140 
 
120 
 
100 
 
80 
 
60 
 
40 
 
20 
 
0 
Tramagal PRC Sines PRC Quarteira PRC 
 
 
 
 
 
 
 
 
 
 
 
 
0 1 2 3 4 5 6 7 
Concentration (mg PRC/ml) 
 
Figure 3.9. Antiproliferative activity of PRCs on HT29 cell line (Incubation time= 72h). 
 
 
The anticancer effect of PRCs could be related with the presence of some phenolic compounds, 
namely betalains and piscidic acid. In fact betalains that were only identified in PRC-Sines and PRC- 
Quarteira (figure  3.7C and D) are already recognized to be powerful antiproliferative compounds 
(Sreekanth, et al., 2007, Stintzing, et al., 2005, Stintzing, et al., 2001). Piscidic acid, a phenolic acid 
present in higher amounts in  PRC-Sines followed by PRC-Quarteira (figure 3.7A), could also be 
considered as one of the compounds responsible for the antiproliferative effect. ED50 values were also 
determined for each PRC samples (table 3.5). PRC-Sines showed the lower ED50 value (3.5 mg/mL) 
followed by PRC-Quarteira and PRC-Tramagal. For this sample ED50 value was not be determined 
being superior to the highest concentration tested (6mg/mL). Furthermore is important to note that all 
PRC samples were not cytotoxic on Caco2 cell model. 
 
 
Table 3.5. ED50 values of PRCs in HT29 cells (Incubation time= 72h). 
 
 
PRCs 
 
ED50  (mg extract/mL) 
 
Tramagal 
 
> 6 
Sines 3,5 
Quarteira 4,6 
 
 
 
 
In order to better understand the antiproliferative effect of PRC-Sines and PRC-Quarteira, flow 
cytometry  was performed for cell cycle arrest analyzes. For that, HT29 cells were treated with 5 
mg/mL of each PRC during 48 and 72 h (figure 3.10). Control was performed with RPMI medium and 
water. 
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Figure 3.10. HT29 cells, in 25 cm2 flask, treated with: A) Control; B) PRC-Sines; C) PRC- Quarteira. 
 
 
Results  obtained (figure 3.11) show that, after 48 and 72  hours of incubation, both PRCs 
increase HT29 population in G1 phase (cell growth phase). At 48h, this increase was more pronounced 
in PRC-Quarteira, and was accompanied by a decrease in both S (DNA replication) and G2/M (cell 
division) phases. After 72 hours of treatment, PRC-Sines showed a significant increase in G1 phase, 
with no cell population in G2/M  phase. Phase contrast images of cells after 48h of PRCs exposure 
confirm that PRC-Sines is more effective  in  inhibiting cancer cell growth (figure 3.12). PRC-Sines 
showed to have the highest inhibitory effect on cancer cell growth inhibition. 
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Figure 3.11. Cell cycle distribution of  HT29 cells incubated with PRC samples (5mg/mL) during  48 and 72 
hours. 
 
 
 
Figure 3.12. Phase contrast images of cells. A) Control (RMPI medium with solvent); B) PRC-Quarteira; C) 
PRC-Sines. Scale bar: 200μm 
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The induction of cell cycle arrest into G1 phase by Opuntia spp.  fruit  extracts is already 
reported by other authors. (Yoon, et al., 2009) showed that Opuntia fruit extracts induced U87MG 
Human Glioblastoma cell cycle arrest in this cell cycle checkpoint after 24h of exposure. Yoon, et al., 
2009 published a similar result using water extracts of O. humifusa fruits in MCF-7 human breast 
cancer cells. Additionally, Zou et al., (2005) showed an increased G1 phase population and decreased 
cells in G2/M and S phases in ovarian and bladder cancer cells incubated with Opuntia extracts. 
In a previous work, doxorubicin, a common drug used in cancer chemotherapy, showed to 
induce  HT29 cell cycle arrest in G2/M phase (Serra, 2010). Therefore, the results obtained in this 
work are very promising for the use of these PRCs as chemotherapeutic agents for colon cancer since 
it has been demonstrated that potent inhibition of tumor survival is achieved when combining drugs 
with different cell cycle check points (Chang, et al., 2001, Li, et al., 1999). 
 
 
3.2.2 Extracts from Opuntia spp.fruit juice residues: conventional solvent extraction (CSE) 
 
and adsorption technology (AD) 
 
The processing of many fruits results in the accumulation of large quantities of residues. Proper 
utilization of these residues could reduce waste disposal problems and serve as a potential new source 
of pytochemicals that can be used in nutraceutical and functional food market. 
The results obtained in this work (section 3.2.1) showed that Sines and Quarteira juices are the 
most promising for the development of PRCs with anticancer effect. For this reason, fruit residues of 
that  samples  were  selected  and  processed  with  clean  technologies  such  as  conventional  solvent 
extraction (CSE)  and adsorption technology (AD) as described in  experimental procedure (2.3.2. and 
2.3.3 sections). At the end, four different extracts were obtained, namely S1, S2, Q1 and Q2 (figure 
 
3.13 and table 3.6), and all were characterized in terms of phytochemical composition, antioxidant 
activity and antiproliferative effect. 
 
 
Table 3.6. Extracts obtained from Sines and Quarteira residues and its PRCs. 
 
Fruit Extract description Abbreviation 
 
Sines 
CSE – Extract (EtOH:H20) obtained from Sines residue S1 
AD – PRC obtained from residue extract S2 
 
Quarteira 
CSE - Extract (EtOH:H20) obtained from Quarteira residue Q1 
AD - PRC obtained from residue extract Q2 
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Figure 3.13. Dried extracts obtained from Sines (S1) and Quarteira (Q1) fruit residues and its PRCs (S2 and Q2, 
respectively). 
 
 
3.2.2.1 Phytochemical and antioxidant characterization 
 
Figure 3.14 shows the total polyphenol content of all extracts. Results showed that the extracts 
obtained after AD application (S2 and Q2) present higher phenolic content than the extracts derived 
from CSE  (S1  and Q1)  with  improvements  of  5  and 8  times  for  Sines  and Quarteira  samples, 
respectively.  The  total  phenolic  content  varied  between  17.5mg  GAE/g  and  142.8  mg  GAE/g 
according with the sample: Q1-17.5 mg GAE/g; S1-26.3 mg GAE/g; Q2-142.8; S2-119.0 mgGAE/g. 
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Figure 3.14. Total polyphenol content of extracts derived from  Sines (S1 and S2) and Quarteira (Q1 and Q2) 
 
residues. 
 
 
 
In figure 3.15 are compared the phenolic profiles of all extracts according with type of residue 
used. In particular, piscidic acid, a phenolic acid that is already identified in PRCs juices, seems to be 
also present in higher amounts in fruit residues (tret=16 min). As shown in both chromatograms, the 
content of piscidic acid is higher in S1, Q1 and S2 extracts than in S2. Regarding S2 and Q2 extracts, 
it is important to mention that these ingredients present higher concentration of flavonoid 
compounds (tret=25 to 70 min) than S1 and Q1.  This result is related with the application of 
Amberlite Xad16 resin, which concentrated all this compounds. Moreover, Q1 extract had more 
betalain compounds than the others, as show in figure 3.15 C and D. 
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Figure 3.15. Chromatograms profiles of S1 (50 mg/ml), S2 (10 mg/ml), Q1(50 mg/ml) and Q2 (10 mg/ml) at A) 
280 nm; B) 360 nm; C) 480 nm; D) 520 nm. Legend: 1- piscidic acid. 
 
The antioxidant  capacity  of residues  extracts  were performed using ORAC  and HORAC 
assays  and results are shown in figure 3.16. As  expected S2 and Q2  had the highest  values  of 
antioxidant activity. 
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Figure 3.16. Antioxidant capacity (ORAC and HORAC) of residues extracts from Sines (S1) and Quarteira (Q1) 
and its respective PRCs (S2 and Q2). 
 
 
In table 3.7, the total polyphenol content, ORAC and HORAC results between Sines and 
Quarteira Opuntia juices residues and their respectives PRCs are compared. In summary, juices were 
the samples with  the  lowest content in phenolic compounds and ORAC and HORAC values. This 
result demonstrated that fruit residues, constituted mainly of peel, are richer sources of bioactive 
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compounds that can be easily extracted by CSE. Therefore, it is more advantageous to process the fruit 
residues  than pulp juices, which are mainly composed by other compounds such as sugars, fibers, 
proteins and  minerals. Another very important fact is that there was a high improvement in TPC, 
ORAC and HORAC  values in both Opuntia juices and residues after submitted to AD technology, 
proving that Amberlite XAD16  resin is a good approach to enhance the bioactive compounds of a 
sample. 
 
 
Table 3.7. Comparison of total polyphenols and antioxidant activity   between juices, residues and respective 
PRCs of Sines and Quarteira Opuntia spp. fruits. 
 
 
Sample ID 
TPC (mgGAE/g 
of dry weight) 
ORAC (µmol 
TE/g dry weight) 
HORAC (µmol 
CAE/g dry weight ) 
 
 
 
Sines 
Juice 3.84 257± 16 142± 13 
 
Juice PRC 
 
161.3 ± 5.1 
 
4164± 209 
 
872± 76 
Residue (S1) 26.3 ± 0.5 968 ± 13 309± 30 
Residue PRC (S2) 119.0 ± 2.0 2326 ± 104 1655± 122 
 
 
Quarteira 
Juice 0.36 79 ± 10 73 ± 10 
Juice PRC 114.6 ± 6.3 1786± 144 571.3 ± 41 
Residue (Q1) 17.5 ± 0.4 562± 13 202 ± 8 
Residue PRC (Q2) 142.8 ± 3.6 2489± 27 1881 ± 106 
 
 
3.2.2.2 Antiproliferative effect 
 
In order to evaluate the anticancer effect, HT29 cells were exposed to all extracts, for 24 hours 
and cell grown inhibition was accessed using CyQuant assay. Dose-dependent curves are presented in 
Figures 3.17 and 3.18. 
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Figure 3.17. Antiproliferative effect of S1 and Q1extracts on HT29 cells. (Incubation time= 24 hours). 
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Figure 3.18. Antiproliferative effect of S2 and Q2on HT29 cells (Incubation time: 24 hours). 
 
 
 
Among all extracts analyzed, S2 and Q2 showed to be the most effective in inhibiting cancer 
cell growth, because lower concentrations were required to reduce cancer cell viability. Between the 
two samples, S2 had the lowest effective dose value (Table 3.8). 
 
 
Table 3.8. ED50 values in HT29 cells after 24h of residues extracts and PRCs exposure. 
 
 ED50 values 
 
Sample ID 
mg 
extract/ml 
 
mg GAE/mL 
S1 > 22,6 - 
Q1 9,59 0,168 
S2 2,40 0,343 
Q2 4,12 0,490 
 
 
Curiously, for the concentrations tested, S1 extract did not show antiproliferative effect. Despite 
the similar values of TPC, ORAC and HORAC values, between S1 and Q1, and the presence of a peak 
at 16 min (piscidic acid, probably) in chromatogram profile, S1 did not inhibit cancer cell growth. This 
result indicates that other compounds can be responsible for the antiproliferative effect. In fact, after 
processed by AD technology, the resulting extract (S2) presented lower quantity of this phenolic acid 
but  exhibit  higher  antiproliferative  effect.  However  further  lab  investigations  will  be  needed  to 
elucidated and find the main responsible compounds for this bioactivity. 
When compared the antiproliferative effect in terms of polyphenolic concentration (figure 3.19), 
it can be conclude that Q1 contains the most effective compounds. In fact for the same polyphenolic 
concentration range, this extract showed to induce lower cell viabilities. Accordingly the ED50 value 
in terms of polyphenols concentration of Q1 extracts was the lowest. The presence of betalain 
compounds in this extract can be responsible for the antiproliferative effect. 
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Figure 3.19. Anticancer effect on HT29 cells after residues extracts of Sines and Quarteira and PRCs exposure 
for 24 hours. The results were presented in total polyphenol content of extracts (mg GAE/mL). 
 
 
 
3.2.3 Extracts from Opuntia spp. fruit juice residues: pressurized liquid extraction (PLE) 
 
In order to overcome the main drawbacks of conventional solvent extraction, other extraction 
methods have been proposed including pressurized liquid extraction (PLE). In PLE, carbon dioxide is 
used in combination with water and/or ethanol at high pressures (forming a gas-expanded liquid) to 
extract pytochemicals from natural sources. In this work, ten extracts obtained with PLE from Opuntia 
ficus-indica fruit residues from Beja were evaluated in terms of bioactive effect. The extracts were 
produced using different  type of solvents. Moreover, in this work, conventional solvent extractions 
with water and/or ethanol were performed (section 2.3.2.1) in order to compare which method is better 
to extract compounds with anticancer effect.  Table 3.9 summarized all the samples analysed. 
 
 
Table 3.9. Extracts obtained from Beja residue using PLE and CSE. 
 
 
Extraction method 
 
Sample ID 
Molar fracctions 
EtOH CO2 H2O 
 
 
 
 
 
 
Pressurized liquid 
extraction (PLE) 
1 1 0 0 
2 0.4 0.6 0 
3 0.4 0 0.6 
4 0.7 0.3 0 
5 0.4 0.3 0.3 
6 0.7 0 0.3 
7 0.8 0.1 0.1 
8 0.5 0.4 0.1 
9 0.5 0.1 0.4 
10 0.6 0.2 0.2 
 
Conventional 
sovent extraction 
(CSE) 
A 1 0 0 
B 0 0 1 
C 0.4 0 0.6 
D 0.7 0 0.3 
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3.2.3.1 Phytochemical and antioxidant characterization 
 
In figure 3.20 is represented the total phenolic content of all CSE and PLE extracts.  It appears 
that  CSE  method  was  more  effective  in  extract  polyphenolic  compounds  than  PLE  technology. 
Extracts B, C, D from CSE and extract 5 from PLE were the ones that presented the highest amount of 
phenolic compounds. 
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Figure 3.20. Total polyphenol content of extracts obtained from Beja residue, using PLE and CSE. 
 
 
Until now, no penolic compounds were identified in all extracts. However, when comparing 
HPLC profiles at 280nm and 360 nm (Figure 3.21) some differences were observed between CSE and 
PLE derived products. 
 
 
 
Figure 3.21. Chromatograms profiles of PLE and CSE extracts (200 mg/ml) at: A) 280nm and B) 
 
360nm. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, A, B, C e D. 
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Overall, the phenolic profiles of CSE extracts are similar between the four samples (A-D). In 
the case of PLE extracts, the major difference occurred in extracts 2 and 4.   Apparently these two 
extracts seemed to  have less  compounds than the others  indicating that the use of these extract 
conditions: 60%CO2:40%EtOH and 30%CO2:70%EtOH, contribute to obtain ingredients with lower 
polyphenolic content. Figures 3.22, 3.23 and 3.24 shows in more detail the difference between CSE 
and PLE ingredients for the same extracting solvent. 
 
 
 
Figure 3.22. Chromatograms profiles of 1, A and B extracts at: A) 280 nm and B) 360 nm 
 
 
 
Figure 3.23. Chromatograms profiles of 3 and C extracts at: A) 280 nm and B) 360 nm. 
 
 
Figure 3.24. Chromatograms profiles of 6 and D extracts at: A) 280 nm and B) 360 nm. 
 
 
In general, chromatograms profiles of CSE extracts show a higher content in polyphenolic 
compounds as demonstrated earlier in TPC quantification (figure 3.20). On the other hand, PLE 
extracts seems to have more flavonoid compounds (t ret =70-80 min). 
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Regarding to antioxidant activity, the results obtained were different than would be expected. 
As mentioned previously, for all Opuntia juices and Opuntia extracts analyzed in this work, ORAC 
values are always higher than HORAC values. This result was verified in CSE extracts (figure 3.25) 
but not in PLE extracts. Curiously, all PLE extracts had higher HORAC values than ORAC values, 
except for extract 10 where both antioxidant results are similar. Among all, extract 2 has the highest 
HORAC values. These results  suggest that PLE and CSE have the ability to extract completely 
different compounds from Beja residue,  with different bioactivities. While CSE have mostly radical 
chain breaking antioxidants, PLE extracts are mainly constitute for preventive antioxidants. 
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Figure 3.25. Antioxidant capacity of extracts obtained from Beja residue, using PLE and CSE. 
 
 
3.2.3.2 Antiproliferative effect 
 
In order to compare the anticancer effect between PLE and CSE extracts, HT29 cells were 
exposed, for 24 hours, at the same extract concentration (0-24 mg/mL) and cell viability was accessed. 
As show in figure 3.26, CSE extracts did not show significant antiproliferative effect. Only 
extract B (extract with 100% of water) have inhibited cell growth at the highest concentration tested - 
cell viability decreased about 50% relative to the control. In contrast, almost all PLE extracts showed 
anticancer effect, except extract 1 and 3 (figure 3.27). It is important to note that these two extracts 
were obtained using 100% ethanol and 40%EtOH:60%H2O, indicating that these solvent combinations 
are not effective in extracting anticancer compounds using the both extraction methods - CSE and 
PLE. On the other hand, PLE – 6 extract, which was extracted using the same type of solvent as CSE- 
D extract - 70% EtOH; 30%H2O2, showed significant antiproliferative effect. This result indicates 
that PLE method contributes to extract more or other compounds with antiproliferative effect. 
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Figure 3.26. Antiproliferative effect on HT29 cell line, after 24 hours of CSE extracts treatment. 
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Figure 3.27. Antiproliferative effect on HT29 cell line, after 24 hours of PLE extracts treatment. 
 
 
 
Among all PLE, extracts 2 (60%CO2:40%EtOH) and 4 (30%CO2:70%EtOH) showed the 
highest  antiproliferative activity indicating that the use of CO2   and EtOH only, is beneficial for the 
extraction of anticancer compounds from Beja residues. The lower TPC values and the fewer content 
in compounds in chromatogram profiles indicate that this anticancer effect can be responsible for other 
compounds that aren`t polyphenols. 
Between the two samples, extract 2 is more effective in inhibiting cancer cell growth. The 
concentration of this extracts required to reduce 50% of cell viability was also determined - 12.3 mg 
extract/ml (figure 3.28). Furthermore, it is important to note that this concentration was not cytotoxic, 
which was evaluated in Caco2 cell model (data not shown). 
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Figure 3.28. Antiproliferative effect on HT29 cell line, after 24 hours of treatment with extract 2. 
 
 
 
 
 
3.3. PART 3: Evaluation of Opuntia spp. extracts as promising bioactive ingredients for colon 
cancer therapy 
 
In this part of the work, the four more promising Opuntia spp. residues extracts described 
previously (section 3.2), namely Q1 (extract obtained through CSE from Quarteira residue), Q2 (PRC 
from Quarteira CSE extract), S2 (PRC from Sines CSE extract) and PLE-2 (extract 2 obtained from 
Beja residue through PLE) were characterized for their anticancer effect. For all, the induction of cell 
cycle arrest was evaluated as well as the generation of intracellular ROS. Additionally, the capacity of 
natural extracts in  reverting chemoresistance of tumor cells was studied on a doxorubicin-resistant 
HT29 cell culture. 
 
 
3.3.1. Cell cycle arrest and monitorization of ROS production 
 
In order to analyze the induction of cell cycle arrest of selected extracts, flow cytometry was 
performed in human colon cancer cell line. HT29 cells were treated with the amount of extract that 
correspond to each ED50 value (Q1=9.6; Q2= 4.1; S2=2.4 and PLE-2= 12.3 mg extract/mL) during 24 
hours. 
 
Results obtained show that extracts had different behaviors in cell cycle arrest (figure 3.29). 
Q1 extract clearly induced cell cycle arrest in the G1 phase (cell growth phase). This effect was similar 
to those  previously verified for the extracts obtained from Quarteira fruit juices  with adsorption 
technology (section 3.2.1), suggesting that both products may contain the same bioactive ingredients. 
On the other hand, S2 extract induced cell cycle arrest in G2/M phase (cell division phase). Results of 
Q2 and PLE-2 extracts showed that the population distribution is similar in all phases of the cell cycle. 
Herein it is important to note that, relatively to control, there is an increase in S phase population in 
Both Q2 and PLE-2 extracts.  
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Figure 3.29. Cell cycle distribution of HT29 cells incubated for 24h with different Opuntia spp. extracts. 
 
 
 
 
The evaluation of cell cycle analysis allowed to conclude that Opuntia extracts obtained from 
different fruits sources and extraction methods have distinct bioactive compounds that are responsible 
for different bioactivities in human colon cancer cell line. 
Since ROS were found to play a pivotal role in the activation of pro-apoptic cell death signals 
under stress conditions such as chemotherapeutic agent treatments (Benhar, et al., 2002, Jackson and 
Loeb, 2001, Pelicano, et al., 2004, Swamy and Huat, 2003), the effect of the four Opuntia extracts on 
ROS generation in HT29 cells was evaluated. For that HT29 cells were treated with 0.5 mg/mL of 
each extract, during 24 hours  and ROS production was assessed by DCFH-DA fluorimetric assay. 
When compared to control, Q1, S2 and  PLE-2 exhibited a significant increase in ROS production 
(figure 3.38). Among all, S2 induced the highest cellular ROS formation. On contrary, Q2 extract did 
not  show  ROS  induction  in  HT29  cells.  Probably  this  happen  because  the  macropouros  resin 
(Amberlite XAD16) was not effective in isolating the responsible compounds for ROS generation in 
Q2  extract.  Overall,  the results  obtained  in this  study suggested that  Opuntia  extracts  (with Q2 
exception) induce cell death through ROS dependent mechanism. 
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Figure 3.30. Effect of Opuntia extracts (0.5 mg/mL) on reactive oxygen species (ROS) accumulation in HT29 
 
cells, after 24h incubation. 
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3.3.2. Chemosensitization effect in a drug resistant cell sub-population (HT29 dx) 
 
Multi-drug resistance (MDR) is actually one of the major factors impairing the success of 
pharmacological treatments of several tumors, such as colon cancer. Recently, several approaches to 
revert  it  have been  studied.  In  cancer  cell  models,  one  of  the  most  studied  mechanisms  is  the 
overexpression  of  several  energy-dependent  drug  efflux  pumps  that  belong  to  the  ATP-binding 
cassette family of  transporters, such as the P-glycoprotein (Pgp) and the MDR associated proteins 
(MDRs) (Riganti, et al., 2005). Evidence that drug efflux pumps play a significant role in clinical drug 
resistance has stimulated the  introduction of new chemical inhibitors compounds into the clinical 
arena such as: Pgp inhibitors (Thomas  and Coley, 2003) and NHE (Na
+
/H
+    
exchanger) inhibitors, 
which are involved in the homeostasis of intracellular pH (Miraglia, et al., 2005). On the other hand, 
there are studies that suggest the utilization of chemical inducers, such as inducers of NO synthesis (i.e 
cytokines), which may increase drug accumulation and a marked reduction on doxorubicin efflux rate 
(De Boo, et al., 2009, Riganti, et al., 2005). Furthermore, a  more recent study suggests that the 
inactivation of RhoA gene (small interfering RNA) subsequently lead to a decrease of RhoA protein, 
which was associated with the increased sensitivity to doxorubicin in HT29 cells  and the complete 
reversion of HT29 dx (Doublier, et al., 2008). These solutions seems to be good enough to reverse 
doxorubicin  resistance,  however,  they  have some  drawbacks.  The use  of  inducers  or  inhibitors, 
consequently leads to the consumption of others chemical drugs, which are responsible for many 
adverse effects and have several contraindications (i.e atorvastatin). Besides that, gene therapy (RhoA 
silencing) is a  complex  and costly  method,  which require other  complementary studies for their 
potential clinical application in humans. 
To  overcome  these  issues,  recently,  natural  compounds  or  extracts  had  been  used  for 
chemiosensitization effect. It has been demonstrated that the Hericium erinaceus (HE) mushroom 
extract in combination with doxorubicin serves as an effective tool for treating drug-resistant human 
hepatocellular carcinoma (Lee and Hong, 2010). 
In this work, the chemosensitization effect of Opuntia-based natural extracts was evaluated in 
a drug-resistant cell line subpopulation (HT29 dx). The aim is to reduce the necessary dose of drug 
decreasing the toxicity associated with it. 
 
 
3.3.2.1 Cellular sensitivity to drug and intracellular accumulation of doxorubicin 
 
The human colon carcinoma resistant cell line (HT29 dx) was created through addition of a 
doxorubicin dose on culture medium during several passages, as previously described in experimental 
procedure. In the end, to evaluate the sensitivity to doxorubicin, both cell lines (HT29 and HT29 dx) 
were exposed to several drug concentrations (0.16-20 µM), for 1 hour. After three days in a drug-free 
medium,  cell  viability  was  performed using  MTT  assay  and  IC50  values  (the  half  maximal  of 
inhibitory concentration of a substance) for each cell line were determined.  
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Figure 3.31. Inhibitory effect of doxorubicin exposure during1 hour, in HT29 cell line and HT29 dx. 
 
 
Table 3.10. IC50 values determined for HT29 cell line and HT29 dx, after 1h drug exposure. 
 
 
 
 
 
 
 
*The resistance index (R.I.) was calculated as the ratio between the IC50 values obtained 
 
 
In figure 3.31, is show that the cell viability line of HT29 dx is above the other line (HT29), 
which demonstrated that effectively HT29 dx was more resistant to doxorubicin. IC50 values are 
presented in table 3.10, being approximately 6 µM for HT29 and 10.2 µM of doxorubicin for HT29 dx. 
To ensure the resistance of HT29 dx, intracellular drug accumulation was  evaluated and 
compared in both cell lines. This was accomplished by incubating cell lines with 5µmol/L of drug 
during 24 hours. After incubation time the fluorescent drug was quantified fluorimetrically and cell 
protein   was   determined   according   to   Bradford   assay.   Fluorescence   was   converted   in   ng 
doxorubicin/mg cell  protein using a calibration curve prepared previously, as show in figure 3.32. 
Results show that HT29 normal cell line accumulated significantly more doxorubicin (almost 50%) 
than the resistant cell line, as expected. These results are a little bit higher than reported in literature 
(De Boo, et al., 2009). 
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Figure 3.32. Intracellular doxorubicin accumulation in HT29 and HT29 dx. 
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3.3.2.2 Chemosensitization activity 
After  the  development  of  HT29  dx  sub  population,  the next  step  of  this  work  was  the 
evaluation of the capacity of Opuntia natural extracts to revert chemoresistance of this resistant cell 
population. For that, HT29 dx cells were exposed to Opuntia extracts (6 mg/ml) for 24 hours, further 1h 
of drug (0-20µM) incubation. After 72 of proliferation, cell viability was accessed and compared. The 
extracts selected for this study were: Q1 extract (extract obtained of CSE with 50%EtOH:50%H2O from 
Quarteira residue) and PLE-2 (extract obtained from Beja residue using PLE with 60%CO2:40% EtOH).  
In figure 3.33 is presented the toxicity of Opuntia extracts conjugated with doxorubicin in HT29 
dx cells. As it can be seen, Q1 extract had the lowest effect on HT29 dx viability. When combined with 
doxorubicin, cell viability was higher or similar to the drug alone, indicating that this ingredient do not 
present chemosensitization effect. 
 
 
Figure 3.33. Toxicity of Q1 and PLE-2 extracts and /or doxorubicin (0-20 µM) on HT29dx cells. 
 
 
On the other hand, PLE-2 extract had the strongest effect on HT29 dx viability. As shown 
in figure 3.33, 6 mg/mL of PLE-2 combined with 5, 10 or 20 µM of doxorubicin reduced HT29 dx 
viability below 80%, which is the effect verified for the highest concentration of drug alone. Moreover, 
when subtracting the toxicity effect of PLE-2 extract it was observed that PLE-2 increased drug 
sensitivity on HT29 dx cell population (figure 3.34). It is important to note that this effect is closer 
than those verified for doxorubicin alone on HT29 normal cell population. 
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Figure 3.34. Toxicity effect of PLE-2 extract plus doxo or using only doxo in HT29 or HT29 dx. 
 
The chemosensitization effect of PLE-2 extract observed in HT29 dx cell population 
suggests that combining this Opuntia extract with doxorubicin may be beneficial to prevent 
chemoresistance of cancer cells.  Therefore, PLE-2 is a promising natural extract to be used in 
combination with the drug in colon cancer treatments. 
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4.Conclusions 
 
In this  work, the bioactive effects of Opuntia spp. fruit juices and Opuntia spp.  - based 
extracts  were investigated in order to recognize their high added-value for colon cancer therapy 
application. It was demonstrated that Opuntia ficus-indica and Opuntia robusta cultivated in Alentejo 
and Algarve can be considered as functional fruits with promising activity in chemotherapy of colon 
cancer. 
 
Five Portuguese Opuntia spp. fruit juices were screened for their bioactivity. Two species of 
Opuntia spp. were studied, namely Opuntia ficus-indica from Tramagal, Sines, Marvão and Beja, and 
Opuntia robusta  collected in Quarteira. Among all Opuntia ficus-indica samples, the juices from 
Tramagal and Sines fruits  have the highest antiproliferative effect in human colon cancer cells, and 
this is mainly related to the highest  content in polyphenols. Despite of Opuntia robusta, have the 
lowest  concentration in polyphenols,  showed  a  significant  antiproliferative effect  on HT29  cells, 
maybe due to the presence  of betalains,  that  are  compounds  identified as  anticancer  substances 
(Sreekanth, et al., 2007). 
Within this  work, efforts were made to develop Opuntia spp. bioactive products such as 
polyphenol-rich concentrates (PRCs) and natural extracts using Opuntia fruit juices and their residues. 
For that different clean technologies were explored such as adsorption technology (AD), conventional 
solvent extraction  (CSE) with biocompatible solvents and pressurized liquid extraction (PLE) with 
CO2:EtOH:H2O different  mixtures. In particular, polyphenols-rich concentrates were obtained with 
juices from Tramagal, Sines and Quarteira using the macroporous adsorptive resin Amberlite XAD16. 
This method allowed the enrichment in polyphenol content and antioxidant capacity of juices, mainly 
in PRC-Quarteira. Only the PRCs from Sines  and Quarteira showed significant cancer cell growth 
inhibition and this effect seemed to be related with the presence of some phenolic compounds namely 
betalains and piscidic acid. The same process was used to isolate polyphenols-rich concentrates from 
Sines and Quarteira fruit juices residues and the products obtained demonstrated an improvement in 
antiproliferative activity in HT29 cell line. For Sines and Quarteira residues conventional extractions 
using  50%EtOH:50%H2O  were  also  performed.  Results  showed  that,  in  terms  of  polyphenols 
compounds, Quarteira conventional extract showed to be more effective in inhibiting cell growth tha n 
PRC from Quarteira. Although adsortive resins contribute to increase the polyphenol content of the 
final product, some bioactive polyphenol compounds with anitproliferative activity were not recovered 
using this process. 
For fruit juice residues from Beja pressurized liquid extraction was explored. Ten different 
extracts  obtained with different CO2:EtOH:H2O ratios were analyzed and the product derived from 
60%CO2and  40%EtOH   extraction  was  the  most  effective  in  inhibiting  cancer   cell  growth. 
Additionally,  when  comparing  with  conventional  extraction,  the  use  of  pressurized  solvents 
contributes to obtain extracts with enhanced antiproliferative effect. 
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In this thesis, the mechanism behind the antiproliferative effect of Opuntia spp. extracts was 
investigated in terms of cell cycle arrest and ROS generation.   The most promising extracts are the 
ones   derived  from  Quarteira,  Sines  and  Beja  fruit  juices  residues  using  conventional  solvent 
extraction,  adsorption  technology  and  pressurized  liquid  extraction  with  60%CO2and 40%EtOH, 
respectively. These  extracts induce cell cycle arrest in different cell cycle checkpoints and increase 
ROS  generation  in  HT29,   playing  an  important  role  in  activation  of  pro-apoptic  cell  death 
mechanisms. Finally, exctract from Beja residue showed to be a promising natural ingredient to be 
used in cancer therapy due to its capacity in reverting chemoresistance of tumor cells. In fact, when 
resistance cancer cells were pré-treated with this extract, their sensitization to the drug increases more 
than 4 times. Moreover, it is important to highlight that  this effect is more pronounced than that 
observed in normal cancer cells with dorxorubicin alone,  suggesting  that some synergetic effects 
occurs between Beja extract and doxorubicin 
Despite the evidence provided by cell culture studies presented in this work, the molecular 
mechanisms responsible for the anticarcinogenic effect of the Opuntia bioactive ingredients need to be 
more  clarified.  Further  studies  will  be  necessary  to  identify  more  compounds  responsible  for 
anticancer  effect  and what  mechanisms are underlying HT29 cell death. Moreover, others future 
investigations should also  be  performed such as: (a) studies about the combined chemopreventive 
effects of Opuntia functional ingredients and doxorubicinin should be further explored through the use 
of extracts with different  compositions, using cell culture, animal models and clinical trials; (b) 
studies on polyphenol bioavailability (eg, intestinal absorption and metabolism) in animal models, to 
better elucidate the chemopreventive properties of its intestinal metabolites; and (c) clinical studies in 
human   subjects   to   fully   confirm   and   quantify    the   bioavailability, safety, efficacy,   and 
chemotherapeutic properties Opuntia polyphenols. 
Overal, this thesis demonstrate that Portuguese Opuntia fruits can be recognized as products 
with bioactivity or as rich sources of high added-value ingredients with promising application in food 
and pharmaceutical industries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
5. References 
 
Alonso-Salces, R. M., E. Korta, A. Barranco, L. A. Berrueta, B. Gallo, and F. Vicente. 'Pressurized Liquid 
Extraction for the Determination of Polyphenols in Apple.', J Chromatogr A Vol. 933, No. 1-2, 37-43, 
2001. 
 
Alía (a), M., R. Mateos, S. Ramos, E. Lecumberri, L. Bravo, and L. Goya. 'Influence of Quercetin and Rutin on 
Growth and Antioxidant Defense System of a Human Hepatoma Cell Line (Hepg2).', Eur J Nutr Vol. 
45, No. 1, 19-28, 2006. 
 
Alía, M., R. Mateos, S. Ramos, E. Lecumberri, L. Bravo, and L. Goya. 'Influence of Quercetin and Rutin on 
Growth and Antioxidant Defense System of a Human Hepatoma Cell Line (Hepg2).', Eur J Nutr Vol. 
45, No. 1, 19-28, 2006. 
 
Alía (b), M., S. Ramos, R. Mateos, A. B. Granado-Serrano, L. Bravo, and L. Goya. 'Quercetin Protects Human 
Hepatoma Hepg2 against Oxidative Stress Induced by Tert-Butyl Hydroperoxide.', Toxicol Appl 
Pharmacol Vol. 212, No. 2, 110-8, 2006. 
 
American Cancer Society. 'Cancer Facts & Figures', American Cancer Society, 2008. 
 
Araújo, J. R., P. Gonçalves, and F. Martel. 'Chemopreventive Effect of Dietary Polyphenols in Colorectal Cancer 
Cell Lines.', Nutr Res Vol. 31, No. 2, 77-87, 2011. 
 
Azeredo, Henriette M.C. 'Betalains: Properties, Sources, Applications, and Stability – a Review', International 
Journal of Food Science and Technology Vol. 44, 2365–2376, 2009. 
 
Barkakatia, Pranab, Ashma Beguma, Makhan Lal Dasb, and Paruchuri Gangadhar Rao. 'Adsorptive Separation 
of Ginsenoside from Aqueous Solution by Polymeric Resins: Equilibrium, Kinetic and Thermodynamic 
Studies', Chemical Engineering Journal Vol. 161, 34–45, 2010. 
 
Benhar, M., D. Engelberg, and A. Levitzki. 'Ros, Stress-Activated Kinases and Stress Signaling in Cancer.', 
EMBO Rep Vol. 3, No. 5, 420-5, 2002. 
 
Bradford, Marion M. 'A Rapid and Sensitive Method for the Quantitation of Microgram  Quantities of Protein 
Utilizing the Principle of Protein-Dye Binding', Analytical Biochemistry Vol. 72, 248-254, 1976. 
 
Brower, V. 'Nutraceuticals: Poised for a Healthy Slice of the Healthcare Market?', Nat Biotechnol Vol. 16, No. 8, 
728-31, 1998. 
 
Butera, D., L. Tesoriere, F. Di Gaudio, A. Bongiorno, M. Allegra, A. M. Pintaudi, R. Kohen, and M. A. Livrea. 
'Antioxidant Activities of Sicilian Prickly Pear (Opuntia Ficus Indica) Fruit Extracts and Reducing 
Properties of Its Betalains: Betanin and Indicaxanthin.', J Agric Food Chem Vol. 50, No. 23, 6895-901, 
2002. 
 
Camel, V. 'Recent Extraction Techniques for Solid Matrices-Supercritical Fluid Extraction, Pressurized Fluid 
Extraction and Microwave-Assisted Extraction: Their Potential and Pitfalls.', Analyst Vol. 126, No. 7, 
1182-93, 2001. 
 
Cartea,  M. E.,  M.  Francisco,  P.  Soengas,  and  P.  Velasco.  'Phenolic Compounds in  Brassica  Vegetables.', 
Molecules Vol. 16, No. 1, 251-80, 2011. 
 
Cayupán,  Yanina  S.  Coria,  María  J.  Ochoa, and  Mónica A.  Nazareno.  'Health-Promoting  Substances  and 
Antioxidant  Properties  of  Opuntia  Sp.  Fruits.  Changes  in  Bioactive-Compound  Contents  During 
Ripening Process', Food Chemistry Vol. 126, 514–519, 2011. 
 
Chang, W., J. J. Kang, K. Y. Lee, K. Wei, E. Anderson, S. Gotmare, J. A. Ross, and G. D. Rosen. 'Triptolide and 
Chemotherapy Cooperate in Tumor Cell Apoptosis. A Role for the P53 Pathway.', J Biol Chem Vol. 
276, 2221-2227, 2001. 
 
 
 
 
55 
Chavez-Santoscoy, R. A., J. A. Gutierrez-Uribe, and S. O. Serna-Saldívar. 'Phenolic Composition, Antioxidant 
Capacity and in Vitro Cancer Cell Cytotoxicity of Nine Prickly Pear (Opuntia Spp.) Juices.', Plant 
Foods Hum Nutr Vol. 64, No. 2, 146-52, 2009. 
 
D'Archivio, M., C. Filesi, R. Di Benedetto, R. Gargiulo, C. Giovannini, and R. Masella. 'Polyphenols, Dietary 
Sources and Bioavailability.', Ann Ist Super Sanita Vol. 43, No. 4, 348-61, 2007. 
 
Dai,  J.,  and  R.  J.  Mumper.  'Plant  Phenolics:  Extraction,  Analysis  and  Their  Antioxidant  and  Ant icancer 
Properties.', Molecules Vol. 15, No. 10, 7313-52, 2010. 
 
De Boo, S., J. Kopecka, D. Brusa, E. Gazzano, L. Matera, D. Ghigo, A. Bosia, and C. Riganti. 'Inos Activity Is 
Necessary for the Cytotoxic and Immunogenic Effects of Doxorubicin in Human Colon Cancer Cells.', 
Mol Cancer Vol. 8, 108, 2009. 
 
Dihal, A. A., R. A. Woutersen, B. van Ommen, I. M. Rietjens, and R. H. Stierum. 'Modulatory Effects of 
Quercetin on Proliferation and Differentiation of the Human Colorectal Cell Line Caco-2.', Cancer Lett 
Vol. 238, No. 2, 248-59, 2006. 
 
Doublier, S., C. Riganti, C. Voena, C. Costamagna, E. Aldieri, G. Pescarmona, D. Ghigo, and A. Bosia. 'Rhoa 
Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells.', Mol Cancer Res Vol. 
6, No. 10, 1607-20, 2008. 
 
Dragnev, K. H., Q. Feng, Y. Ma, S. J. Shah, C. Black, V. Memoli, W. Nugent, J. R. Rigas, S. Kitareewan, S. 
Freemantle, and E. Dmitrovsky. 'Uncovering Novel Targets for  Cancer Chemoprevention.',  Recent 
Results Cancer Res Vol. 174, 235-43, 2007. 
 
Espín,  J.  C.,  M.  T.  García-Conesa,  and  F.  A.  Tomás-Barberán.  'Nutraceuticals:  Facts  and  Fiction.', 
Phytochemistry Vol. 68, No. 22-24, 2986-3008, 2007. 
 
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, and Parkin DM. 'Cancer Incidence and Mortality Worldwide: 
Iarc Cancerbase, GLOBOCAN 2008, International Agency for Research on Cancer, 2010. 
 
Fernández-López, J. A., L. Almela, J. M. Obón, and R. Castellar. 'Determination of Antioxidant Constituents in 
Cactus Pear Fruits.', Plant Foods Hum Nutr Vol. 65, No. 3, 253-9, 2010. 
 
Ferreira, C. G., M. Epping, F. A. Kruyt, and G. Giaccone. 'Apoptosis: Target of Cancer Therapy.', Clin Cancer 
Res Vol. 8, No. 7, 2024-34, 2002. 
 
Feugang, J. M., P. Konarski, D. Zou, F. C. Stintzing, and C. Zou. 'Nutritional and Medicinal Use of Cactus Pear 
(Opuntia Spp.) Cladodes and Fruits.', Front Biosci Vol. 11, 2574-89, 2006. 
 
Galati, E. M., M. R. Mondello, D. Giuffrida, G. Dugo, N. Miceli, S. Pergolizzi, and M. F. Taviano. 'Chemical 
Characterization  and  Biological  Effects  of  Sicilian  Opuntia  Ficus  Indica  (L.)  Mill.  Fruit  Juice: 
Antioxidant and Antiulcerogenic Activity.', J Agric Food Chem Vol. 51, No. 17, 4903-8, 2003. 
 
Gordaliza, M. 'Natural Products as Leads to Anticancer Drugs.', Clin Transl Oncol Vol. 9, No. 12, 767-76, 2007. 
Gottesman, M. M. 'Mechanisms of Cancer Drug Resistance.', Annu Rev Med Vol. 53, 615-27, 2002. 
Griffith,  M.  Patrick.  'The  Origins  of  an  Important  Cactus  Crop,  Opuntia  Ficus-Indica  (Cactaceae):  New 
Molecular Evidence', American Journal of Botany Vol. 91, No. 11, 1915–1921, 2004. 
 
Gurrieri, S., L. Miceli, C. M. Lanza, F. Tomaselli, R. P. Bonomo, and E. Rizzarelli. 'Chemical Characterization 
of Sicilian Prickly Pear (Opuntia Ficus Indica) and Perspectives for the Storage of Its Juice.', J Agric 
Food Chem Vol. 48, No. 11, 5424-31, 2000. 
 
Hahm, S. W., J. Park, and Y. S. Son. 'Opuntia Humifusa Partitioned Extracts Inhibit the Growth of U87mg 
Human Glioblastoma Cells.', Plant Foods Hum Nutr Vol. 65, No. 3, 247-52, 2010. 
 
 
 
 
56
Haque, N., U. Salma, T. R. Nurunnabi, A. K. Haque, I. J. Mukti, S. Pervin, and R. Nahar. 'Lifestyle Related 
Causes of Cancer and Chemoprevention through Phytonutrients.', Pak J Biol Sci Vol. 13, No. 19, 916- 
26, 2010. 
 
Hernández-Pérez,  T.,  A.  Carrillo-López,  F.  Guevara-Lara,  A.  Cruz-Hernández,  and  O.  Paredes-López. 
'Biochemical and Nutritional Characterization of Three Prickly Pear Species with Different Ripening 
Behavior.', Plant Foods Hum Nutr Vol. 60, No. 4, 195-200, 2005. 
 
Howard, L., and N. Pandjaitan. 'Pressurized Liquid Extraction of Flavonoids from Spinach.', J Food Sci Vol. 73, 
No. 3, C151-7, 2008. 
 
Huang, D., B. Ou, M. Hampsch-Woodill, J. A. Flanagan, and R. L. Prior. 'High-Throughput Assay of Oxygen 
Radical Absorbance Capacity (Orac) Using a Multichannel Liquid Handling System Coupled with a 
Microplate Fluorescence Reader in 96-Well Format.', J Agric Food Chem Vol. 50, No. 16, 4437-44, 
2002. 
 
Hwang, J. T., J. Ha, and O. J. Park. 'Combination of 5-Fluorouracil and Genistein Induces Apoptosis 
Synergistically in Chemo-Resistant Cancer Cells through the Modulation of Ampk and Cox-2 Signaling 
Pathways.', Biochem Biophys Res Commun Vol. 332, No. 2, 433-40, 2005. 
 
Ignat,  Ioana,  Volf  Irina,  and  Valentim  I.  Popa.  'A  Critical  Review  of  Methods  for  Characterisation  of 
Polyphenolic Compounds in Fruits and Vegetables', Food Chemistry Vol. 126, 1821-1825, 2011. 
Invitrogen. 'Cyquant Cell Proliferation Assay Kit', In Invitrogen detection technologies Molecular Probes, 2006. 
Jackson, A. L., and L. A. Loeb. 'The Contribution of Endogenous Sources of Dna Damage to the Multiple 
Mutations in Cancer.', Mutat Res Vol. 477, No. 1-2, 7-21, 2001. 
 
Jaganath, Indu B., and Alan Crozier. Dietary Flavonoids and Phenolic Compounds. Plant Phenolics and Human 
Health: Biochemistry, Nutrition, and Pharmacology, John Wiley & Sons, Inc., 2010. 
Johnson, I. T. 'Phytochemicals and Cancer.', Proc Nutr Soc Vol. 66, No. 2, 207-15, 2007. 
Kushi, L. H., T. Byers, C. Doyle, E. V. Bandera, M. McCullough, A. McTiernan, T. Gansler, K. S. Andrews, M. 
J. Thun, and American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory 
Committee. 'American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer 
Prevention: Reducing the Risk of Cancer  with  Healthy Food Choices and Physical Activity.',  CA 
Cancer J Clin Vol. 56, No. 5, 254-81; quiz 313-4, 2006. 
 
Kuti, Joseph O. 'Antioxidant Compounds from Four Opuntia Cactus Pear Fruit Varieties', Food Chemistry Vol. 
85, 527–533, 2004. 
 
Lambert, J. D., J. Hong, G. Y. Yang, J. Liao, and C. S. Yang. 'Inhibition of Carcinogenesis by Polyphenol s: 
Evidence from Laboratory Investigations.', Am J Clin Nutr Vol. 81, No. 1 Suppl, 284S-291S, 2005. 
 
Lee,  J.  S.,  and  E.  K.  Hong.  'Hericium  Erinaceus  Enhances  Doxorubicin -Induced  Apoptosis  in  Human 
Hepatocellular Carcinoma Cells.', Cancer Lett Vol. 297, No. 2, 144-54, 2010. 
 
Lee, Y.-C., Y.-H. Pyo, C.-K. Ahn, and S.-H. Kim. 'Food Functionality of Opuntia Ficus-Indica Var. Cultivated 
in Jeju Island', J Food Sci Nutr Vol. 10, 103-110, 2005. 
 
Li, C. J., Y. Z. Li, A. V. Pinto, and A. B. Pardee. 'Potent Inhibition  of Tumor Survival in Vivo by Beta- 
Lapachone Plus Taxol: Combining Drugs Imposes Different Artificial Checkpoints.', Proc Natl Acad 
Sci U S A Vol. 96, No. 23, 13369-74, 1999. 
 
Lila, M. A. 'From Beans to Berries and Beyond: Teamwork between Plant Chemicals for Protection of Optimal 
Human Health.', Ann N Y Acad Sci Vol. 1114, 372-80, 2007. 
 
Loro, J. F., I. del Rio, and L. Pérez-Santana. 'Preliminary Studies of Analgesic and Anti-Inflammatory Properties 
of Opuntia Dillenii Aqueous Extract.', J Ethnopharmacol Vol. 67, No. 2, 213-8, 1999. 
 
 
57 
Luthria, D. L., and S. Mukhopadhyay. 'Influence of Sample Preparation on Assay of Phenolic Acids from 
Eggplant.', J Agric Food Chem Vol. 54, No. 1, 41-7, 2006. 
 
Manach,  C.,  A.  Scalbert,  C.  Morand,  C.  Rémésy,  and  L.  Jiménez.  'Polyphenols:  Food  Sources  and 
Bioavailability.', Am J Clin Nutr Vol. 79, No. 5, 727-47, 2004. 
 
Manson, M. M., P. B. Farmer, A. Gescher, and W. P. Steward. 'Innovative Agents in Cancer Prevention.', Recent 
Results Cancer Res Vol. 166, 257-75, 2005. 
 
Medina, E.M. Días, E.M. Rodríguez Rodríguez, and C. Díaz Romero. 'Chemical Characterization of Opuntia 
Dillenii and Opuntia Ficus Indica Fruits', Food Chemistry Vol. 103, 38–45, 2007. 
 
Miraglia, E., D. Viarisio, C. Riganti, C. Costamagna, D. Ghigo, and A. Bosia. 'Na+/H+ Exchanger Activity Is 
Increased in Doxorubicin-Resistant Human Colon Cancer Cells and Its Modulation Modifies the 
Sensitivity of the Cells to Doxorubicin.', Int J Cancer Vol. 115, No. 6, 924-9, 2005. 
 
Naczk, M., and F. Shahidi. 'Phenolics in Cereals, Fruits and Vegetables: Occurrence, Extraction and Analysis.', J 
Pharm Biomed Anal Vol. 41, No. 5, 1523-42, 2006. 
 
Nakagawa, H., K. Hasumi, J. T. Woo, K. Nagai, and M. Wachi. 'Generation of Hydrogen Peroxide Primarily 
Contributes to the Induction of Fe(Ii)-Dependent Apoptosis in Jurkat Cells by (-)-Epigallocatechin 
Gallate.', Carcinogenesis Vol. 25, No. 9, 1567-74, 2004. 
 
Neveu, V., J. Perez-Jiménez, F. Vos, V. du Crespy, L. Chaffaut, L. Mennen, C. Knox, R. Eisner, J. Cruz, D. 
Wishart,  and  A.  Scalbert.  'Phenol-Explorer:  An  Online  Comprehensive  Database  on  Polyphenol 
Contents in Foods'. Phenol-Explorer: an online comprehensive database on polyphenol contents in 
foods, 2010. 
 
Ou, B., M. Hampsch-Woodill, J Flanagan, E. K. Deemer, R. L. Prior, and D. Huang. 'Novel Fluorometric Assay 
for Hydroxyl Radical Prevention Capacity Using Fluorescein as the Probe', J. Agric. Food Chem Vol. 
50, 2772-2777, 2002. 
 
Pelicano, H., D. Carney, and P. Huang. 'Ros Stress in Cancer Cells and Therapeutic Implications.', Drug Resist 
Updat Vol. 7, No. 2, 97-110, 2004. 
 
Piga, Antonio. 'Cactus Pear: A Fruit of Nutraceutical and Functional Importance', Journal of the Professional 
Association of Cactus Development, 9 - 22, 2004. 
 
Piñeiro, Z., M. Palma, and C. G. Barroso. 'Determination of Trans-Resveratrol in Grapes by Pressurised Liquid 
Extraction and Fast High-Performance Liquid Chromatography.', J Chromatogr A Vol. 1110, No. 1-2, 
61-5, 2006. 
 
Promega Corporation. 'Celltiter 96® Aqueous One Solution Cell Proliferation Assay', In Promega Corporation, 
2009. 
 
Rajamanickam, S., and R. Agarwal. 'Natural Products and Colon Cancer: Current Status and Future Prospects.', 
Drug Dev Res Vol. 69, No. 7, 460-471, 2008. 
 
Ramadan,  Mohamed  Fawzy,  and  Jorg-Thomas  Morsel.  'Oil  Cactus  Pear  (Opuntia  Ficus-Indica  L.)',  Food 
Chemistry Vol. 82, 339–345, 2003. 
 
Ramos, S. 'Cancer Chemoprevention and Chemotherapy: Dietary Polyphenols and Signalling Pathways.', Mol 
Nutr Food Res Vol. 52, No. 5, 507-26, 2008. 
 
Ravizza, R., M. B. Gariboldi, L. Passarelli, and E. Monti. 'Role of the P53/P21 System in the Response of 
Human Colon Carcinoma Cells to Doxorubicin.', BMC Cancer Vol. 4, 92, 2004. 
 
 
 
 
 
58 
Riganti, C., E. Miraglia, D. Viarisio, C. Costamagna, G. Pescarmona, D. Ghigo, and A. Bosia. 'Nitric Oxide 
Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux.', 
Cancer Res Vol. 65, No. 2, 516-25, 2005. 
 
Rowley, P. T. 'Inherited Susceptibility to Colorectal Cancer.', Annu Rev Med Vol. 56, 539-54, 2005. 
 
Saenz, Carmen. 'Processing Technologies: An Alternative for Cactus Pear (Opuntia Spp.) Fruits and Cladodes', 
Journal of Arid Environments Vol. 46, No. 209–225, 2000. 
 
Sambuy, Y., I. De Angelis, G. Ranaldi, M. L. Scarino, A. Stammati, and F. Zucco. 'The Caco-2 Cell Line as a 
Model  of  the  Intestinal  Barrier:  Influence  of  Cell  and  Culture-Related  Factors  on  Caco-2  Cell 
Functional Characteristics.', Cell Biol Toxicol Vol. 21, No. 1, 1-26, 2005. 
 
Sarkar, F. H., and Y. Li. 'Using Chemopreventive Agents to Enhance the Efficacy of Cancer Therapy.', Cancer 
Res Vol. 66, No. 7, 3347-50, 2006. 
 
Scalbert, A., C. Manach, C. Morand, C. Rémésy, and L. Jiménez. 'Dietary Polyphenols and the Prevention of 
Diseases.', Crit Rev Food Sci Nutr Vol. 45, No. 4, 287-306, 2005. 
 
Scalbert, A., and G. Williamson. 'Dietary Intake and Bioavailability of Polyphenols.', J Nutr Vol. 130, No. 8S 
Suppl, 2073S-85S, 2000. 
 
Schonn, I., J. Hennesen, and D. C. Dartsch. 'Ku70 and Rad51 Vary in Their Importance for the Repair of 
Doxorubicin- Versus Etoposide-Induced Dna Damage.', Apoptosis Vol. 16, No. 4, 359-69, 2011. 
 
Scordino, M., A. Di Mauro, A. Passerini, and E. Maccarone. 'Adsorption of Flavonoids on Resins: Hesperidin.', 
J Agric Food Chem Vol. 51, No. 24, 6998-7004, 2003. 
 
Seabra, Inês J., Mara Elga Braga, Maria Teresa Batista, and Hermínio C. Sousa. 'Effect of Solvent 
(Co2/Ethanol/H2o) on the Fractionated Enhanced Solvent Extraction of Anthocyanins from Elderberry 
Pomace', J. of Supercritical Fluids Vol. 54, 145–152, 2010. 
 
Seeram, N. P., M. Aviram, Y. Zhang, S. M. Henning, L. Feng, M. Dreher, and D. Heber. 'Compar ison of 
Antioxidant Potency of Commonly Consumed Polyphenol-Rich Beverages in the United States.', J 
Agric Food Chem Vol. 56, No. 4, 1415-22, 2008. 
 
Serra, Ana Teresa. 'Valorization of Traditional Portuguese Apples and Cherries. Biochemical Characterization 
and Development of Functional Ingredients', ITQB-UNL/IBET Nutraceuticals and Controlled Delivery 
Laboratory, 2010. 
 
Singleton, V.L., and J. A. Jr Rossi. 'Colorunetry of Total Phenolics with Phosphomolybdic-Phosphotungstic 
Acid Reagents.', Amer. J. Enol. Viticult. Vol. 16, 144-58, 1965. 
 
Sonee, M., T. Sum, C. Wang, and S. K. Mukherjee. 'The Soy Isoflavone, Genistein, Protects Human Cortical 
Neuronal Cells from Oxidative Stress.', Neurotoxicology Vol. 25, No. 5, 885-91, 2004. 
 
Soto, María Luisa, Andrés Moure, Herminia Domínguez, and Juan Carlos Parajó. 'Recovery, Concentration and 
Purification of Phenolic Compounds by Adsorption: A Review', Journal of Food Engineering Vol. 105, 
1-27, 2011. 
 
Sreekanth, D., M. K. Arunasree, K. R. Roy, T. Chandramohan Reddy, G. V. Reddy, and P. Reddanna. 'Betanin a 
Betacyanin Pigment Purified from Fruits of Opuntia Ficus-Indica Induces Apoptosis in Human Chronic 
Myeloid Leukemia Cell Line-K562.', Phytomedicine Vol. 14, No. 11, 739-46, 2007. 
 
Stintzing, F. C., and R. Carle. 'Cactus Stems (Opuntia Spp.): A Review on Their Chemistry, Technology, and 
Uses.', Mol Nutr Food Res Vol. 49, No. 2, 175-94, 2005. 
 
Stintzing, F. C., K. M. Herbach, M. R. Mosshammer, R. Carle, W. Yi, S. Sellappan, C. C. Akoh, R. Bun ch, and 
P. Felker. 'Color, Betalain Pattern, and Antioxidant Properties of Cactus Pear (Opuntia Spp.) Clones.', J 
Agric Food Chem Vol. 53, No. 2, 442-51, 2005. 
 
 
59 
Stintzing, Florian C., Andreas Schieber, and Reinhold Carle. 'Phytochemical and Nutritional Significance of 
Cactus Pear', Eur Food Res Technol Vol. 212, 396–407, 2001. 
 
Supino, R. 'Mtt Assays', In O'Hare SM and Atterwill CK. (Eds.), In in Methods in Molecular Biology: In Vitro 
Toxicity Testing Protocols, Humana Press, 1998. 
 
Surh, Y. J. 'Cancer Chemoprevention with Dietary Phytochemicals.', Nat Rev Cancer Vol. 3, No. 10, 768-80, 
2003. 
 
Swamy, S. M., and B. T. Huat. 'Intracellular Glutathione Depletion and Reactive Oxygen Species Generation 
Are Important in Alpha-Hederin-Induced Apoptosis of P388 Cells.', Mol Cell Biochem Vol. 245, No. 1- 
2, 127-39, 2003. 
 
Tavares, L., D. Carrilho, M. Tyagi, D. Barata, A. T. Serra, C. M. Duarte, R. O. Duarte, R. P. Feliciano, M. R. 
Bronze, P. Chicau, M. D. Espírito-Santo, R. B. Ferreira, and C. N. dos Santos. 'Antioxidant Capacity of 
Macaronesian Traditional Medicinal Plants.', Molecules Vol. 15, No. 4, 2576-92, 2010. 
 
Tesoriere (a), L., M. Fazzari, M. Allegra, and M. A. Livrea. 'Biothiols, Taurine, and Lipid-Soluble Antioxidants 
in the Edible Pulp of Sicilian Cactus Pear (Opuntia Ficus-Indica) Fruits and Changes of Bioactive Juice 
Components Upon Industrial Processing.', J Agric Food Chem Vol. 53, No. 20, 7851-5, 2005. 
 
Tesoriere, L., D. Butera, A. M. Pintaudi, M. Allegra, and M. A. Livrea. 'Supplementation with Cactus Pear 
(Opuntia Ficus-Indica) Fruit Decreases Oxidative Stress in Healthy Humans: A Comparative Study 
with Vitamin C.', Am J Clin Nutr Vol. 80, No. 2, 391-5, 2004. 
 
Tesoriere, L., M. Fazzari, M. Allegra, and M. A. Livrea. 'Biothiols, Taurine, and Lipid-Soluble Antioxidants in 
the Edible Pulp of Sicilian Cactus Pear (Opuntia Ficus-Indica) Fruits and Changes of Bioactive Juice 
Components Upon Industrial Processing.', J Agric Food Chem Vol. 53, No. 20, 7851-5, 2005. 
 
Thomas, H., and H. M. Coley. 'Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Str ategy 
of Inhibiting P-Glycoprotein.', Cancer Control Vol. 10, No. 2, 159-65, 2003. 
 
Tomás-Barberán, F. A., M. I. Gil, P. Cremin, A. L. Waterhouse, B. Hess-Pierce, and A. A. Kader. 'Hplc-Dad- 
Esims Analysis of Phenolic Compounds in Nectarines, Peaches, and Plums.', J Agric Food Chem Vol. 
49, No. 10, 4748-60, 2001. 
 
Utkarsha, U. Shedbalkar, S. Adki Vinayak, P. Jadhav Jyoti, and A. Bapat Vishwas. ' Opuntia and Other Cacti: 
Applications and Biotechnological Insights', Tropical Plant Biol. Vol. 3, 136-150, 2010. 
 
Vainio, H., and E. Weiderpass. 'Fruit and Vegetables in Cancer Prevention.', Nutr Cancer Vol. 54, No. 1, 111- 
42, 2006. 
 
van der Woude, H., A. Gliszczyńska-Swigło, K. Struijs, A. Smeets, G. M. Alink, and I. M. Rietjens. 'Biphasic 
Modulation of Cell Proliferation by Quercetin at Concentrations Physiologically Relevant in Humans.', 
Cancer Lett Vol. 200, No. 1, 41-7, 2003. 
 
Vincent,  T. L., and R. A. Gatenby. 'An  Evolutionary Model  for  Initiation, Promotion, and Progression  in 
Carcinogenesis.', Int J Oncol Vol. 32, No. 4, 729-37, 2008. 
 
WCRF/AICR. 'World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical 
Activity, and the Prevention of Cancer: A Global Perspective', 2007. 
 
WCRF/AICR, (b). 'Continuous Update Project Interim Report Summary. Food, Nutrition, Physical Activity, and 
the Prevention of Colorectal Cancer' ', World Cancer Research Fund / American Institute for Cancer 
Research, 2011 
 
Wolfe, K. L., and R. H. Liu. 'Cellular Antioxidant Activity (Caa) Assay for Assessing Antioxidants, Foods, and 
Dietary Supplements.', J Agric Food Chem Vol. 55, No. 22, 8896-907, 2007. 
 
 
 
 
60 
Xu, B. J., and S. K. Chang. 'A Comparative Study on Phenolic Profiles and Antioxidant Activities of Legumes as 
Affected by Extraction Solvents.', J Food Sci Vol. 72, No. 2, S159-66, 2007. 
 
Yoon, JA., SW. Hahm, J. Park, and YS. Son. 'Total Polyphenol and Flavonoid of Fruit Extract of Opuntia 
Humifusa and Its Inhibitory Effect on the Growth of Mcf-7 Human Breast Cancer Cells', J Korean Soc 
Food Sci Nutr Vol. 38, 1679–1684, 2009. 
 
Young, G. P., Y. Hu, R. K. Le Leu, and L. Nyskohus. 'Dietary Fibre and Colorectal Cancer: A Model for 
Environment--Gene Interactions.', Mol Nutr Food Res Vol. 49, No. 6, 571-84, 2005. 
Zeisel, S. H. 'Regulation Of "Nutraceuticals".', Science Vol. 285, No. 5435, 1853-5, 1999. 
Zhishen, Jia, Tang Mengcheng, and Wu Jianming. 'The Determination of Flavonoid Contents in Mulberry and 
Their Scavenging Effects on Superoxide Radicals', Food Chemistry Vol. 64, 555-559, 1999. 
 
Zitka, O., J. Sochor, O. Rop, S. Skalickova, P. Sobrova, J. Zehnalek, M. Beklova, B. Krska, V. Adam, and R. 
Kizek. 'Comparison of Various Easy-to-Use Procedures for Extraction of Phenols from Apricot Fruits.', 
Molecules Vol. 16, No. 4, 2914-36, 2011. 
 
Zou, D. M., M. Brewer, F. Garcia, J. M. Feugang, J. Wang, R. Zang, H. Liu, and C. Zou. 'Cactus Pear: A Natural 
Product in Cancer Chemoprevention.', Nutr J Vol. 4, 25, 2005. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
6. Appendix 
 
 
 
Appendix A – Cellular viability assays 
 
 
 
 
 CellTiter 96
®  
AQueous One Solution Cell Proliferation Assay 
 
The CellTiter 96
®   
AQueous One Solution Cell Proliferation Assay is a colorimetric method 
for determining the number of viable cells in proliferation or cytotoxicity assays. This assay contain 
the   MTS   tetrazolium   compound   (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- 
sulfophenyl)-2H-tetrazolium), which is bioreduced by cells into a colored formazan product that is 
soluble in tissue culture medium (Promega Corporation, 2009). Briefly, after removed the medium 
was  added  100  µL  of  a  MTS  solution  (16.6%  MTS  diluted  10x  and  83,3%  of  RPMI  medium 
0.5%FBS) to each well. After 4 hours at 37ºC in a humidified, 5% CO2 atmosphere the absorbance 
was read in a 96-well plate reader at 490nm (Powerwave XS Microplate Spectrophotometer, Biotek, 
Winooski, USA). The quantity of formazan product measured by the absorbance at 490nm is directly 
proportional to the number of living cells in culture. 
 
 
 
 CyQUANT Cell Proliferation Assay Kit 
 
The CyQUANT Cell Proliferation Assay Kit provides a fast, sensitive, and convenient method 
both for counting cells in a population and for measuring their proliferative activity. The CyQUANT 
assay uses a green-fluorescent CyQUANT
®  
GR dye, which exhibits strong fluorescence enhancement 
when bound to cellular nucleic acids (Invitrogen, 2006). Briefly, the culture medium was removed and 
wash 2X with phosphate buffered saline, pH=7.4 (PBS). The cells were freeze in the microplate and 
store at -70ºC until samples are to be assayed. The freezing step is important for efficient cell lysis in 
the CyQUANT assay. One day after, microplates were thaw at room temperature and was added 200 
µL of the CyQUANT
®  
GR dye/cell lysis buffer to each sample well and mixed gently. Samples were 
 
incubated ate room temperature for 2-5 minutes, protected from light. The fluorescence was measured 
on a  FL800 microplate fluorescent reader (Bioteck Instruments, USA) with filters appropriate for 
~480nm excitation and ~520 nm emission maxima. 
 
 
 
 MTT 
 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a yellow tetrazole) is 
reduced  to a purple formazan product by mitochondrial reductase enzymes active cell viability in 
viable cells and  therefore the amount of formazan product is proportional to the number of viable 
cells. Briefly, the medium was removed and 100 μL of the colorimetric reagent MTT (0.5mg/mL) was 
added to each well and the microplate was incubated for 4 hours. The reaction was stopped with 
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DMSO (150μL/well) and formazan was quantified by measurement of the absorbance at 570 nm in a 
 
microplate reader Spectrophotometer Powerwave XS, Biotek Instruments (Winooski, USA) 
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